{"288931":{"#nid":"288931","#data":{"type":"news","title":"Class Notes: Stem Cell Engineering with Classmates from Cali to MIT","body":[{"value":"\u003Cp\u003EThe 10 graduate students are discussing stem cell population analysis, when it\u2019s time. Before they can continue the discussion, Todd McDevitt, the instructor, has to do one thing \u2014 turn on the TV.\u003C\/p\u003E\u003Cp\u003E\u201cThat\u2019s the beauty of this class, not only is the topic of stem cell engineering unique, but thanks to video conferencing technology, Georgia Tech students can now take a class with their peers from across the country,\u201d said McDevitt, an associate professor in the Wallace H. Coulter Department of Biomedical Engineering.\u003C\/p\u003E\u003Cp\u003EStem Cell Engineering (BMED 8813) has been offered since the spring of 2011 and was created by McDevitt as a way to educate graduate students about a research area that is becoming increasingly popular.\u003C\/p\u003E\u003Cp\u003EIncluding the 10 students at Tech, there are 39 students enrolled in this semester\u2019s course. Aside from Tech, they are located at Washington University, the Massachusetts Institute of Technology, Boston University, University of California, Merced, and the University of Wisconsin. And although this is a graduate-level course, undergraduates can take the course with McDevitt\u2019s permission.\u003C\/p\u003E\u003Cp\u003ESo what can students expect during a week of classes? On Tuesdays, students from all of the participating campuses hear a lecture via the video conferencing system on a stem cell engineering topic \u2014 think everything from stem cell biology basics to stem cell biomanufacturing.\u003C\/p\u003E\u003Cp\u003EWhen the class meets on Thursdays, two students (at each location) typically lead a 50-minute discussion on a recently published journal article related to the lecture topic to their in-person peers.\u003C\/p\u003E\u003Cp\u003EThen, for the remainder of class, the Tech group video conferences with the students at other locations to discuss the key points brought up by each local group.\u003C\/p\u003E\u003Cp\u003E\u201cIt\u2019s very helpful to have the perspective of students and faculty from other universities,\u201d\u0026nbsp; said Jenna Wilson, a Ph.D. student in the bioengineering program who is a former student of the course turned teaching assistant. \u201cBecause people at other universities have different areas of research expertise, they can provide greater insight into aspects of the stem cell engineering field and pose interesting questions for discussion.\u201d\u003C\/p\u003E\u003Cp\u003EWilson also appreciated the small class size and discussion format of the course.\u003C\/p\u003E\u003Cp\u003E\u201cBoth aspects allow for great conversations with other students and some of the leading faculty in the stem cell engineering field,\u201d she added. \u201cEven though the class is broadcast across six universities, it\u0027s still a small group where you can feel comfortable sharing ideas and opinions.\u201d\u003C\/p\u003E\u003Cp\u003EThe course is typically offered during spring semester. For more information, email \u003Ca href=\u0022mailto:todd.mcdevitt@bme.gatech.edu\u0022\u003EMcDevitt \u003C\/a\u003E.\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EThe 10 graduate students are discussing stem cell population analysis, when it\u2019s time. Before they can continue the discussion, Todd McDevitt, the instructor, has to do one thing \u2014 turn on the TV.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"The 10 graduate students are discussing stem cell population analysis, when it\u2019s time. Before they can continue the discussion, Todd McDevitt, the instructor, has to do one thing \u2014 turn on the TV."}],"uid":"27445","created_gmt":"2014-04-07 15:26:49","changed_gmt":"2016-10-08 03:16:11","author":"Amelia Pavlik","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2014-04-07T00:00:00-04:00","iso_date":"2014-04-07T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"288921":{"id":"288921","type":"image","title":"Class Notes: BMED 8813","body":null,"created":"1449244274","gmt_created":"2015-12-04 15:51:14","changed":"1475894986","gmt_changed":"2016-10-08 02:49:46","alt":"Class Notes: BMED 8813","file":{"fid":"199174","name":"classnotes_stemcellfinal_0.jpg","image_path":"\/sites\/default\/files\/images\/classnotes_stemcellfinal_0_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/classnotes_stemcellfinal_0_0.jpg","mime":"image\/jpeg","size":253889,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/classnotes_stemcellfinal_0_0.jpg?itok=nEdVANuv"}}},"media_ids":["288921"],"related_links":[{"url":"http:\/\/www.ibb.gatech.edu\/","title":"Petit Institute for Bioengineering and Bioscience"},{"url":"http:\/\/www.bme.gatech.edu\/facultystaff\/faculty_record.php?id=78","title":"Todd McDevitt"},{"url":"http:\/\/mcdevitt.gatech.edu\/","title":"McDevitt Research Lab"}],"groups":[{"id":"1259","name":"Whistle"}],"categories":[{"id":"129","name":"Institute and Campus"}],"keywords":[{"id":"91121","name":"BMED 8813"},{"id":"89341","name":"class notes"},{"id":"3322","name":"classes"},{"id":"167603","name":"Stem Cell Engineering"}],"core_research_areas":[],"news_room_topics":[{"id":"71871","name":"Campus and Community"}],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:amelia.pavlik@comm.gatech.edu\u0022\u003EAmelia Pavlik\u003C\/a\u003E\u003Cbr \/\u003EInstitute Communications\u003C\/p\u003E","format":"limited_html"}],"email":[],"slides":[],"orientation":[],"userdata":""}},"254651":{"#nid":"254651","#data":{"type":"news","title":"Todd McDevitt and Krishnendu Roy Recognized for Breakthrough Research and Leadership  In Immunoengineering and Regenerative Medicine","body":[{"value":"\u003Cp\u003EThe University System of Georgia Board of Regents has approved the appointment of Krishnendu (Krish) Roy and Todd McDevitt to Carol Ann and David D. Flanagan Faculty Professorships in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. \u0026nbsp;These appointments, generously endowed by the Flanagans in 2011, serve to recognize and reward faculty that are conducting high impact research and are exemplary citizens of the Wallace H. Coulter department and Georgia Tech as a whole. \u0026nbsp;Both Roy and McDevitt are bringing cutting-edge research and thought leadership to the burgeoning fields of immunoengineering and regenerative medicine.\u003C\/p\u003E\u003Cp\u003EMcDevitt is an associate professor in the Coulter Department, a Petit Faculty Fellow in the Petit Institute for Bioengineering and Bioscience, and director of the Stem Cell Engineering Center at Georgia Tech. The objective of McDevitt\u2019s research program is to develop enabling technologies for the directed differentiation of stem cells for regenerative medicine, disease models, and diagnostic applications. Much of his research focuses on the application of technologies to engineer stem cell fate, on stem cell bioprocessing and on engineering regenerative therapies from stem cells. McDevitt has garnered more than $9 million in funding, including a Transformative R01 award from the NIH and an NSF IGERT on Stem Cell Biomanufacturing. He received the 2010 Society for Biomaterials Young Investigator Award, a New Investigator Award from the American Heart Association and was recognized as one of the \u201c40 Under 40\u201d by \u003Cem\u003EGeorgia Trend\u003C\/em\u003E magazine. McDevitt graduated cum laude from Duke University, with a B.S.E. and a double major in Biomedical and Electrical Engineering. He received his Ph.D. in 2001 in Bioengineering from the University of Washington, where he worked for Patrick S. Stayton, and where he conducted post-doctoral research in the pathology laboratory of Charles E. Murry.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003ERoy joined the Coulter Department this summer as professor and is currently the director of the Center for Immunoengineering.\u0026nbsp; He is an elected Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and a Fellow of the Biomedical Engineering Society (BMES). He received his B.S. from the Indian Institute of Technology, M.S. from Boston University and his Ph.D. in Biomedical Engineering from Johns Hopkins University. Following his Ph.D., he joined a start-up biotechnology company, Zycos Inc., where he served as a senior scientist in drug delivery research.\u0026nbsp; He joined The University of Texas at Austin in 2002, where most recently he was professor of Biomedical Engineering. He also served as the director of the graduate program and as associate chair for education and outreach. His research interests are in the areas of immunoengineering with particular focus on material-directed cells signaling and immune cell generation and controlled drug and vaccine delivery technologies with applications in cancer and immunotherapies.\u0026nbsp; Roy has received the Young Investigator Awards from The Society for Biomaterials (SFB) and the Controlled Release Society (CRS). He has been extensively funded by NIH, NSF, the Coulter Foundation, the Whitaker Foundation and the Cancer Prevention And Research Institute of Texas, among others. He serves as a member of the editorial boards for the Journal of Controlled Release and the European Journal of Pharmaceutics and Biopharmaceutics.\u003C\/p\u003E\u003Cp\u003EGeorgia Tech and Emory created the joint department of biomedical engineering in the fall of 1997. The collaborative relationship blends the expertise of medical researchers at the Emory University School of Medicine with that of the engineering faculty at Georgia Tech, and is the first of its kind between a public and private institution. The collaboration has resulted in a biomedical engineering program that consistently ranks among the top five in the nation by\u003Cem\u003E U.S. News \u0026amp; World Report.\u003C\/em\u003E\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Flanagans Support Novel, High-Impact Biomedical Research with Endowment"}],"field_summary":[{"value":"\u003Cp\u003EThe University System of Georgia Board of Regents has approved the appointment of Krishnendu (Krish) Roy and Todd McDevitt to Carol Ann and David D. Flanagan Faculty Professorships in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. \u0026nbsp;These appointments, generously endowed by the Flanagans in 2011, serve to recognize and reward faculty that are conducting high impact research and are exemplary citizens of the Wallace H. Coulter department and Georgia Tech as a whole. \u0026nbsp;Both Roy and McDevitt are bringing cutting-edge research and thought leadership to the burgeoning fields of immunoengineering and regenerative medicine.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"The University System of Georgia Board of Regents has approved the appointment of Krishnendu (Krish) Roy and Todd McDevitt to Carol Ann and David D. Flanagan Faculty Professorships in the Wallace H. Coulter Department of Biomedical Engineering."}],"uid":"27182","created_gmt":"2013-11-14 15:15:41","changed_gmt":"2016-10-08 03:15:22","author":"Adrianne Proeller","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2013-11-14T00:00:00-05:00","iso_date":"2013-11-14T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"243221":{"id":"243221","type":"image","title":"Dr. Krishnendu Roy","body":null,"created":"1449243704","gmt_created":"2015-12-04 15:41:44","changed":"1475894919","gmt_changed":"2016-10-08 02:48:39","alt":"Dr. Krishnendu Roy","file":{"fid":"197851","name":"roy-agarwal_0.jpg","image_path":"\/sites\/default\/files\/images\/roy-agarwal_0_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/roy-agarwal_0_0.jpg","mime":"image\/jpeg","size":88915,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/roy-agarwal_0_0.jpg?itok=4Esyg2Dq"}},"254661":{"id":"254661","type":"image","title":"Todd McDevitt","body":null,"created":"1449243828","gmt_created":"2015-12-04 15:43:48","changed":"1475894934","gmt_changed":"2016-10-08 02:48:54","alt":"Todd McDevitt","file":{"fid":"198186","name":"todd_mcdevitt_lab.jpg","image_path":"\/sites\/default\/files\/images\/todd_mcdevitt_lab_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/todd_mcdevitt_lab_0.jpg","mime":"image\/jpeg","size":4014690,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/todd_mcdevitt_lab_0.jpg?itok=TebBWi34"}}},"media_ids":["243221","254661"],"related_links":[{"url":"http:\/\/www.bme.gatech.edu\/facultystaff\/faculty_record.php?id=173","title":"Krishnendu Roy"},{"url":"http:\/\/www.bme.gatech.edu\/facultystaff\/faculty_record.php?id=78","title":"Todd McDevitt"}],"groups":[{"id":"1254","name":"Wallace H. Coulter Dept. of Biomedical Engineering"}],"categories":[{"id":"129","name":"Institute and Campus"},{"id":"42941","name":"Art Research"},{"id":"140","name":"Cancer Research"},{"id":"146","name":"Life Sciences and Biology"},{"id":"135","name":"Research"}],"keywords":[{"id":"249","name":"Biomedical Engineering"},{"id":"5775","name":"Bioscience Research"},{"id":"25821","name":"Georgia Tech \u0026 Emory Center for Regenerative Medicine (GTEC)"},{"id":"73511","name":"immunoengineering"},{"id":"75821","name":"Immunoengineering Center"},{"id":"167130","name":"Stem Cells"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"}],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003EAdrianne Proeller\u003C\/p\u003E","format":"limited_html"}],"email":["adrianne.proeller@bme.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"204991":{"#nid":"204991","#data":{"type":"news","title":"Adhesive Differences Enable Separation of Stem Cells to Advance Potential Therapies","body":[{"value":"\u003Cp\u003EA new separation process that depends on an easily-distinguished physical difference in adhesive forces among cells could help expand production of stem cells generated through cell reprogramming. By facilitating new research, the separation process could also lead to improvements in the reprogramming technique itself and help scientists model certain disease processes.\u003C\/p\u003E\u003Cp\u003EThe reprogramming technique allows a small percentage of cells \u2013 often taken from the skin or blood \u2013 to become human induced pluripotent stem cells (hiPSCs) capable of producing a wide range of other cell types. Using cells taken from a patient\u2019s own body, the reprogramming technique might one day enable regenerative therapies that could, for example, provide new heart cells for treating cardiovascular disorders or new neurons for treating Alzheimer\u2019s disease or Parkinson\u2019s disease.\u003C\/p\u003E\u003Cp\u003EBut the cell reprogramming technique is inefficient, generating mixtures in which the cells of interest make up just a small percentage of the total volume. Separating out the pluripotent stem cells is now time-consuming and requires a level of skill that could limit use of the technique \u2013 and hold back the potential therapies.\u003C\/p\u003E\u003Cp\u003ETo address the problem, researchers at the Georgia Institute of Technology have demonstrated a tunable process that separates cells according to the degree to which they adhere to a substrate inside a tiny microfluidic device. The adhesion properties of the hiPSCs differ significantly from those of the cells with which they are mixed, allowing the potentially-therapeutic cells to be separated to as much as 99 percent purity.\u003C\/p\u003E\u003Cp\u003EThe high-throughput separation process, which takes less than 10 minutes to perform, does not rely on labeling technologies such as antibodies. Because it allows separation of intact cell colonies, it avoids damaging the cells, allowing a cell survival rate greater than 80 percent. The resulting cells retain normal transcriptional profiles, differentiation potential and karyotype.\u003C\/p\u003E\u003Cp\u003E\u201cThe principle of the separation is based on the physical phenomenon of adhesion strength, which is controlled by the underlying biology,\u201d said \u003Ca href=\u0022http:\/\/www.me.gatech.edu\/faculty\/garcia\u0022\u003EAndr\u00e9s Garc\u00eda\u003C\/a\u003E, the study\u2019s principal investigator and a professor in Georgia Tech\u2019s \u003Ca href=\u0022http:\/\/www.me.gatech.edu\/\u0022\u003EWoodruff School of Mechanical Engineering\u003C\/a\u003E and the \u003Ca href=\u0022http:\/\/www.ibb.gatech.edu\/\u0022\u003EPetit Institute for Bioengineering and Bioscience\u003C\/a\u003E. \u201cThis is a very powerful platform technology because it is easy to implement and easy to scale up.\u201d\u003C\/p\u003E\u003Cp\u003EThe separation process was described April 7 in the advance online publication of the journal \u003Cem\u003ENature Methods\u003C\/em\u003E. The research was supported by the \u003Ca href=\u0022http:\/\/www.nih.gov\/\u0022\u003ENational Institutes of Health\u003C\/a\u003E (NIH) and the \u003Ca href=\u0022http:\/\/www.nsf.gov\/\u0022\u003ENational Science Foundation\u003C\/a\u003E (NSF), supplemented by funds from the American Recovery and Reinvestment Act (ARRA).\u003C\/p\u003E\u003Cp\u003E\u201cThe scientists applied their new understanding of the adhesive properties of human pluripotent stem cells to develop a quick, efficient method for isolating these medically important cells,\u201d said Paula Flicker, of the National Institutes of Health\u2019s \u003Ca href=\u0022http:\/\/www.nigms.nih.gov\/\u0022\u003ENational Institute of General Medical Sciences\u003C\/a\u003E, which partly funded the research. \u201cTheir work represents an innovative conversion of basic biological findings into a strategy with therapeutic potential.\u201d \u0026nbsp;\u003C\/p\u003E\u003Cp\u003EAn improved separation technique is essential for converting the human induced pluripotent stem cells produced by reprogramming into viable therapies, said \u003Ca href=\u0022http:\/\/www.bme.gatech.edu\/facultystaff\/faculty_record.php?id=78\u0022\u003ETodd McDevitt\u003C\/a\u003E, an associate professor in the \u003Ca href=\u0022http:\/\/www.bme.gatech.edu\/\u0022\u003EWallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University\u003C\/a\u003E, and director of Georgia Tech\u2019s \u003Ca href=\u0022http:\/\/scec.gatech.edu\/\u0022\u003EStem Cell Engineering Center\u003C\/a\u003E.\u003C\/p\u003E\u003Cp\u003E\u201cFor research purposes, depending on labeling reagents for separation is not a major problem,\u201d said McDevitt, one of the paper\u2019s co-authors. \u201cBut when we move into commercialization and manufacturing of cell therapies for humans, we need a technology approach that is unbiased and able to be scaled up.\u201d\u003C\/p\u003E\u003Cp\u003EThe separation technique, called micro stem cell high-efficiency adhesion-based recovery (\u00b5SHEAR), will allow standardization across laboratories, providing consistent results that don\u2019t depend on the skill level of the users.\u0026nbsp; \u201cBecause of the engineering and technology involved, and the characterization work, we now have a technology that is readily transferrable,\u201d McDevitt said.\u003C\/p\u003E\u003Cp\u003EThe \u00b5SHEAR process grew out of an understanding of how cells involved in the reprogramming process change morphologically as the process proceeds. Using a spinning disk device, the researchers tested the adhesive properties of the hiPSCs, the parental somatic cells, partially-reprogrammed cells and reprogrammed cells that had begun differentiating. For each cell type, they measured its \u201cadhesive signature\u201d \u2013 the level of force required to detach the cells from a substrate that had been coated with specific proteins.\u0026nbsp; \u0026nbsp;\u003C\/p\u003E\u003Cp\u003EThe research team, which included Georgia Tech postdoctoral fellows Ankur Singh and Shalu Suri, tested their technique in microfluidic devices developed in collaboration with \u003Ca href=\u0022http:\/\/www.chbe.gatech.edu\/faculty\/lu\u0022\u003EHang Lu\u003C\/a\u003E, a professor in Georgia Tech\u2019s \u003Ca href=\u0022http:\/\/www.chbe.gatech.edu\/\u0022\u003ESchool of Chemical and Biomolecular Engineering\u003C\/a\u003E.\u003C\/p\u003E\u003Cp\u003EIn the testing, cells from the culture were first allowed to attach to the substrate before being subjected to the flow of buffer fluid. Cells with a lower adhesive signature detached from the substrate at lower flow rates. By varying the flow rate, the researchers were able to separate specific types of cells, allowing production of stem cell cultures with purity as high as 99 percent \u2013 from mixtures in which those cells accounted for only a few percent of the total.\u003C\/p\u003E\u003Cp\u003E\u201cAt different stages of reprogramming, we see differences in the molecular composition and distribution of the cellular structures that control adhesion force,\u201d Garc\u00eda explained. \u201cOnce we know the range of adhesive forces for each cell type, we can apply those narrow ranges to select the populations that come off in each range.\u201d\u003C\/p\u003E\u003Cp\u003EUsing inexpensive disposable \u201ccassettes,\u201d the microfluidic system could be scaled up to increase the volume of cells produced and to provide specific separations, Garc\u00eda noted.\u003C\/p\u003E\u003Cp\u003EUnlike existing labeling techniques, the new separation process works on cell colonies, avoiding the need to risk damaging cells by breaking up colonies for separation. The separation process has been tested with both reprogrammed blood and skin cells. Cells were provided for testing by ArunA Biomedical, a company based in Athens, Ga., founded by \u003Ca href=\u0022http:\/\/stice.uga.edu\/\u0022\u003EUniversity of Georgia professor Steven Stice\u003C\/a\u003E.\u003C\/p\u003E\u003Cp\u003EBeyond the direct application in producing stem cells, the separation technique could also help scientists with other research in which cells need to be separated \u2013 including potential improvements in the reprogramming technique, which won the Nobel Prize for medicine in 2012.\u003C\/p\u003E\u003Cp\u003E\u201cCell reprogramming has been a black box,\u201d said McDevitt. \u201cYou start the reprogramming process, and when the cells are fully reprogrammed, you can pick them out visually. But there are really interesting scientific questions about this process, and by isolating cells undergoing reprogramming, we may be able to make new discoveries about how the process occurs.\u201d\u003C\/p\u003E\u003Cp\u003EIn addition to those already mentioned, the project also included graduate student Ted Lee and research technician Marissa Cooke of Georgia Tech, researcher Jamie Chilton of ArunA, and Weiqiang Chen and Jianping Fu of the University of Michigan.\u003C\/p\u003E\u003Cp\u003E\u003Cem\u003EThis work was supported by an ARRA supplement to the National Institutes of Health (NIH) awards R01 GM065918 and R43 NS080407, the Stem Cell Engineering Center at Georgia Tech, a Sloan Foundation Fellowship, by the National Science Foundation under award DBI-0649833 and an ARRA sub-award under grant RC1CA144825, and by NSF award CMMI-1129611, the Georgia Tech-Emory Center for Regenerative Medicine (GTEC) and the Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech. Any conclusions are those of the authors and do not necessarily represent the official positions of the NIH or NSF.\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003ECITATION\u003C\/strong\u003E: Singh, Ankur, et al., \u201cAdhesion strength\u2013based, label-free isolation of human pluripotent stem cells,\u201d (Nature Methods, 2013). \u003Ca href=\u0022http:\/\/dx.doi.org\/10.1038\/nmeth.2437\u0022\u003Ehttp:\/\/dx.doi.org\/10.1038\/nmeth.2437\u003C\/a\u003E\u003Cbr \/\u003E\u003Cbr \/\u003E\u003Cstrong\u003EResearch News\u003C\/strong\u003E\u003Cbr \/\u003E\u003Cstrong\u003EGeorgia Institute of Technology\u003C\/strong\u003E\u003Cbr \/\u003E\u003Cstrong\u003E177 North Avenue\u003C\/strong\u003E\u003Cbr \/\u003E\u003Cstrong\u003EAtlanta, Georgia\u0026nbsp; 30332-0181\u0026nbsp; USA\u003C\/strong\u003E\u003Cbr \/\u003E\u003Cbr \/\u003E\u003Cstrong\u003EMedia Relations Contact\u003C\/strong\u003E: John Toon (404-894-6986)(\u003Ca href=\u0022mailto:jtoon@gatech.edu\u0022\u003Ejtoon@gatech.edu\u003C\/a\u003E).\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EWriter\u003C\/strong\u003E: John Toon\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EA new separation process that depends on an easily-distinguished physical difference in adhesive forces among cells could help expand production of stem cells generated through cell reprogramming. By facilitating new research, the separation process could also lead to improvements in the reprogramming technique itself and help scientists model certain disease processes.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"A separation technique based on adhesive force differences could advance stem cell therapies."}],"uid":"27303","created_gmt":"2013-04-07 10:46:47","changed_gmt":"2016-10-08 03:13:59","author":"John Toon","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2013-04-07T00:00:00-04:00","iso_date":"2013-04-07T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"204931":{"id":"204931","type":"image","title":"Stem cell separation microfluidics1","body":null,"created":"1449179967","gmt_created":"2015-12-03 21:59:27","changed":"1475894861","gmt_changed":"2016-10-08 02:47:41","alt":"Stem cell separation microfluidics1","file":{"fid":"196695","name":"adhesion-signature55.jpg","image_path":"\/sites\/default\/files\/images\/adhesion-signature55_1.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/adhesion-signature55_1.jpg","mime":"image\/jpeg","size":2061220,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/adhesion-signature55_1.jpg?itok=C44xxCeH"}},"204961":{"id":"204961","type":"image","title":"Stem cell separation device closeup","body":null,"created":"1449179967","gmt_created":"2015-12-03 21:59:27","changed":"1475894861","gmt_changed":"2016-10-08 02:47:41","alt":"Stem cell separation device closeup","file":{"fid":"196698","name":"adhesion-signature95.jpg","image_path":"\/sites\/default\/files\/images\/adhesion-signature95_1.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/adhesion-signature95_1.jpg","mime":"image\/jpeg","size":1986105,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/adhesion-signature95_1.jpg?itok=kA6RKN3L"}},"204921":{"id":"204921","type":"image","title":"Stem cell separation researchers","body":null,"created":"1449179967","gmt_created":"2015-12-03 21:59:27","changed":"1475894861","gmt_changed":"2016-10-08 02:47:41","alt":"Stem cell separation researchers","file":{"fid":"196694","name":"adhesion-signature20.jpg","image_path":"\/sites\/default\/files\/images\/adhesion-signature20_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/adhesion-signature20_0.jpg","mime":"image\/jpeg","size":2069678,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/adhesion-signature20_0.jpg?itok=s_wbPKBn"}},"204951":{"id":"204951","type":"image","title":"Stem cell separation microfluidics2","body":null,"created":"1449179967","gmt_created":"2015-12-03 21:59:27","changed":"1475894861","gmt_changed":"2016-10-08 02:47:41","alt":"Stem cell separation microfluidics2","file":{"fid":"196697","name":"adhesion-signature63.jpg","image_path":"\/sites\/default\/files\/images\/adhesion-signature63_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/adhesion-signature63_0.jpg","mime":"image\/jpeg","size":1862810,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/adhesion-signature63_0.jpg?itok=ITTvOycZ"}},"204981":{"id":"204981","type":"image","title":"Stem cell separation human fibroblast cells","body":null,"created":"1449179967","gmt_created":"2015-12-03 21:59:27","changed":"1475894861","gmt_changed":"2016-10-08 02:47:41","alt":"Stem cell separation human fibroblast cells","file":{"fid":"196700","name":"adhesion-signature-nucleus.jpg","image_path":"\/sites\/default\/files\/images\/adhesion-signature-nucleus_1.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/adhesion-signature-nucleus_1.jpg","mime":"image\/jpeg","size":859307,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/adhesion-signature-nucleus_1.jpg?itok=AQou49qC"}}},"media_ids":["204931","204961","204921","204951","204981"],"groups":[{"id":"1188","name":"Research Horizons"}],"categories":[{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"}],"keywords":[{"id":"63481","name":"adhesive force"},{"id":"539","name":"Andres Garcia"},{"id":"63471","name":"cell reprogramming"},{"id":"14219","name":"Coulter Department of Biomedical Engineering"},{"id":"63501","name":"Petit Institute for Bioengineering and Bioscience"},{"id":"63491","name":"pluripotent"},{"id":"167377","name":"School of Mechanical Engineering"},{"id":"169566","name":"separation"},{"id":"167413","name":"Stem Cell"},{"id":"760","name":"Todd McDevitt"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"}],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003EJohn Toon\u003C\/p\u003E\u003Cp\u003EResearch News\u003C\/p\u003E\u003Cp\u003E\u003Ca href=\u0022mailto:jtoon@gatech.edu\u0022\u003Ejtoon@gatech.edu\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003E(404) 894-6986\u003C\/p\u003E","format":"limited_html"}],"email":["jtoon@gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"173981":{"#nid":"173981","#data":{"type":"news","title":"Emory\/Georgia Tech Regenerative Engineering and Medicine Center Awards 11 Collaborative Seed Grants","body":[{"value":"\u003Cp\u003EThe Emory\/Georgia Tech Regenerative Engineering and Medicine Center recently awarded 11 seed grants, totaling $630,000,\u0026nbsp;for promising new research in regenerative medicine. The seed grants focus on how the body\u2014including bone, muscle, nerves, blood vessels and tissues\u2014can harness its own potential to heal or regenerate following trauma or disease.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003E\u201cWe looked for projects along the innovation spectrum, including early-stage projects for which the potential payoffs justified taking the risk and projects supported by preliminary data that were at an advanced preclinical or early clinical stage,\u201d said Regenerative Engineering and Medicine Center Co-Director Robert Guldberg, a mechanical engineering professor at Georgia Tech. Guldberg is also executive director of the Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003ETwenty-eight seed grant proposals from across the Georgia Tech and Emory campuses were submitted and those with the strongest potential for impacting the field of regenerative medicine were selected for funding.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003E\u201cWe are very excited that the funded proposals will initiate new partnerships among regenerative medicine researchers at institutions across Atlanta,\u201d said Regenerative Engineering and Medicine Center Co-Director W. Robert Taylor, the Marcus Chair in Vascular Medicine and Director of the Division of Cardiology at the Emory University School of Medicine. Taylor is also a professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003EThe collaborative regenerative medicine initiative at Georgia Tech and Emory University began in 1998 with the establishment of the Georgia Tech\/Emory Center for the Engineering of Living Tissues (GTEC), a National Science Foundation Engineering Research Center. Since then, more than 15 technologies have been licensed, 13 startup companies have been formed and three clinical trials are under way.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003EToday, more than 40 researchers from Georgia Tech and Emory University are working together as members of the Regenerative Engineering and Medicine Center, which launched in 2011, to develop integrated technologies and therapies that harness the body\u2019s own cells and repair mechanisms to heal itself.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003EAn interdisciplinary team of stem cell biologists, stem cell engineers and a surgeon from Georgia Tech, Emory University and Morehouse College received one of the $50,000 seed grants. The team plans to improve the quality of stem cells derived from the bone marrow of individuals with critical limb ischemia so that they can be used as a cellular therapy to prevent amputation in this patient population. Critical limb ischemia\u2014a severe blockage in the arteries of the lower extremities that reduces blood flow\u2014affects more than 500,000 people annually and can cause pain, tissue loss and lead to amputation.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003E\u201cMesenchymal stem cells derived from the bone marrow of healthy individuals have been shown to support new blood vessel growth and help re-establish blood flow to an affected area, but the quality of mesenchymal stem cells in individuals with critical limb ischemia is known to be poor because of the typical patient\u2019s age and medical condition,\u201d said Luke Brewster, an assistant professor in the Department of Surgery at Emory University.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003ETo overcome this challenge, the research team plans to develop techniques for rejuvenating mesenchymal stem cells cultured from amputated ischemic patient limbs in a novel manner that will enhance cell expansion and reduce the inflammatory response.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003EIn addition to Brewster, the research team also includes Todd McDevitt, an associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University; Ian Copland, an assistant professor in the Department of Hematology and Medical Oncology at Emory University; and Alex Peister, an assistant professor in the Department of Biology at Morehouse College.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003EJulie Champion, an assistant professor in the School of Chemical and Biomolecular Engineering at Georgia Tech, received a $50,000 seed grant to create an innovative biomaterial capable of suppressing immune activity in the body. The material, which is made from engineered regulatory T-cell proteins, will operate through direct contact with immune cells.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003EThe success of many regenerative medicine therapies is limited because the introduction of foreign biomaterials, cells or tissues into the body causes an inflammatory response. According to Champion, the new material she is developing could be incorporated into regenerative biomaterials directly, combined with cell or tissue therapies, or used as pre-treatments prior to regenerative therapy to suppress immune activity.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003E\u201cThis project demonstrates a new biomaterials platform that will interact directly with the immune system in both a physical and biological manner and could lead to innovative immune therapies for injured or sick patients that require regenerative medicine to heal and restore function,\u201d said Champion.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003EA committee of investigators from Georgia Tech, Emory University, Children\u2019s Healthcare of Atlanta and the University of Georgia awarded the grants that spanned basic science and translational research to researchers from a broad range of disciplines including engineering, medicine and biology.\u003C\/p\u003E\u003Cp\u003E\u003Cbr \/\u003EScores were based on the following primary criteria:\u003C\/p\u003E\u003Cul\u003E\u003Cli\u003Ethe ability of the project to address an important clinical problem;\u003C\/li\u003E\u003Cli\u003Ethe originality and innovation of the research; and\u003C\/li\u003E\u003Cli\u003Ethe quality and expertise of the research and investigator(s).\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003E\u003Cbr \/\u003E\u201cThe seed grants also allow the unique blend of engineers, scientists and clinicians at Georgia Tech and Emory University who have a successful history of collaboration in regenerative engineering and medicine to help train the next generation of leaders in this rapidly growing, interdisciplinary field,\u201d said Guldberg.\u003Cbr \/\u003E\u003Cbr \/\u003EBy: Abby Robinson, writer\u003Cbr \/\u003E\u003Cbr \/\u003E\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Grants focus on how the body harnesses its own potential to heal or regenerate following trauma or disease"}],"field_summary":[{"value":"\u003Cp\u003EEmory\/Georgia Tech Regenerative Engineering and Medicine Center Awards 11 Collaborative Seed Grants, totaling $630,000.\u0026nbsp;Grants focus on how the body harnesses its own potential to heal or regenerate following trauma or disease.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Grants focus on how the body harnesses its own potential to heal or regenerate following trauma or disease"}],"uid":"27195","created_gmt":"2012-11-29 09:40:15","changed_gmt":"2016-10-08 03:13:18","author":"Colly Mitchell","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2012-12-20T00:00:00-05:00","iso_date":"2012-12-20T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"178371":{"id":"178371","type":"image","title":"Julie Champion","body":null,"created":"1449179039","gmt_created":"2015-12-03 21:43:59","changed":"1475894825","gmt_changed":"2016-10-08 02:47:05","alt":"Julie Champion","file":{"fid":"195956","name":"13c7029-p1-009.jpg","image_path":"\/sites\/default\/files\/images\/13c7029-p1-009_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/13c7029-p1-009_0.jpg","mime":"image\/jpeg","size":1681555,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/13c7029-p1-009_0.jpg?itok=3FRW7NNy"}},"178351":{"id":"178351","type":"image","title":"Todd McDevitt, Luke Brewster, Jenna Wilson","body":null,"created":"1449179039","gmt_created":"2015-12-03 21:43:59","changed":"1475894825","gmt_changed":"2016-10-08 02:47:05","alt":"Todd McDevitt, Luke Brewster, Jenna Wilson","file":{"fid":"195954","name":"13c7029-p1-032.jpg","image_path":"\/sites\/default\/files\/images\/13c7029-p1-032_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/13c7029-p1-032_0.jpg","mime":"image\/jpeg","size":1702067,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/13c7029-p1-032_0.jpg?itok=3c6q_rJ7"}},"178361":{"id":"178361","type":"image","title":"Bob Guldberg","body":null,"created":"1449179039","gmt_created":"2015-12-03 21:43:59","changed":"1475894825","gmt_changed":"2016-10-08 02:47:05","alt":"Bob Guldberg","file":{"fid":"195955","name":"13c7029-p1-037.jpg","image_path":"\/sites\/default\/files\/images\/13c7029-p1-037_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/13c7029-p1-037_0.jpg","mime":"image\/jpeg","size":1792562,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/13c7029-p1-037_0.jpg?itok=KaXcmx9e"}}},"media_ids":["178371","178351","178361"],"related_links":[{"url":"http:\/\/regenerativeengineeringandmedicine.com\/","title":"Regenerative Engineering \u0026 Medicine Website"},{"url":"http:\/\/www.ibb.gatech.edu\/","title":"Petit Institute for Bioengineering and Bioscience"},{"url":"http:\/\/mcdevitt.gatech.edu\/","title":"McDevitt Research Lab"},{"url":"http:\/\/champion.chbe.gatech.edu\/Champion.html","title":"Champion Research Lab"},{"url":"http:\/\/medicine.emory.edu\/divisions\/cardiology\/","title":"W. Robert Taylor, Director"},{"url":"http:\/\/guldberglab.gatech.edu\/","title":"Guldberg Musculoskeletal Research Lab"}],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[],"keywords":[{"id":"53551","name":"Endogenous repair"},{"id":"10961","name":"julie champion"},{"id":"1489","name":"Regenerative Medicine"},{"id":"11629","name":"Robert Guldberg"},{"id":"167130","name":"Stem Cells"},{"id":"760","name":"Todd McDevitt"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"}],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:mcdevitt@ibb.gatech.edu\u0022\u003EMegan McDevitt\u003C\/a\u003E\u003Cbr \/\u003EParker H. Petit Institute for Bioengineering and Bioscience\u003Cbr \/\u003E\u003Cbr \/\u003E\u003Ca href=\u0022mailto:jtoon@gatech.edu\u0022\u003EJohn Toon\u003C\/a\u003E\u003Cbr \/\u003EInstitute Communications\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E","format":"limited_html"}],"email":["mcdevitt@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"149331":{"#nid":"149331","#data":{"type":"news","title":"New Video - BioEngineering Graduate Program at Georgia Tech","body":[{"value":"\u003Cp\u003EA new video has been launched for the BioEngineering Graduate program at Georgia Tech. The video showcases BioEngineering program faculty and students from different schools and departments at Georgia Tech and Emory University and highlights the diversity of research projects available within the program. The theme of the video, \u0022BioE is the degree for me!\u0022 emphasizes the creativity and flexibility of the program. \u003Cbr \/\u003E\u003Cbr \/\u003E\u0022The program has never had marketing support before,\u0022 stated Megan McDevitt, director of communications and marketing for the Parker H. Petit Institute for Bioengineering and Bioscience. \u0022This program is one of Georgia Tech\u0027s best kept secrets, and I look forward to telling the program\u0027s story through various communication channels.\u0022 \u003Cbr \/\u003E\u003Cbr \/\u003EThe Georgia Tech Interdisciplinary Bioengineering Graduate Program was established in 1992. Although created twenty years ago, the program reflects Georgia Tech\u0027s strategic vision as it blends traditional academic colleges and units and allows students from very different backgrounds to chart their own path by integrating engineering with life sciences. \u003Cbr \/\u003E\u003Cbr \/\u003EGraduate students choose a \u0022home school\/department\u0022 in any one of the four Georgia Tech colleges, however, through the support of the BioEngineering Graduate program, they can then choose to take classes in almost any relevant subject and conduct research with any one of the over \u003Ca href=\u0022http:\/\/bioengineering.gatech.edu\/program-faculty\u0022\u003E90 participating faculty\u003C\/a\u003E. This allows tremendous diversity and flexibility for classes, research topics and faculty advisors which literally translates into the student creating their perfect path. \u003Cbr \/\u003E\u003Cbr \/\u003E\u0022Gone are the days of traditional, prescribed graduate studies. Students need the flexibility to create their own program,\u0022 said Andres Garcia, PhD, director of the program. \u0022If a student comes from a strong engineering background, they can tailor their coursework towards the basic sciences, if they have a strong science background, they can dive into the engineering. The BioEngineering Program also provides the flexibility to do cross-disciplinary training across engineering sub-fields. It is completely up to them.\u0022 \u003Cbr \/\u003E\u003Cbr \/\u003EOver 185 students have graduated from the program working with faculty from the Colleges of Engineering, Computing, Sciences, and Architecture as well as Emory University School of Medicine. The program welcomes its newest class of 21 graduate students.\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Ranked 2nd in the nation by US News and World Report"}],"field_summary":[{"value":"\u003Cp\u003EThe BioE Graduate PhD and MS program is a unique and interdisciplinary program ranked 2nd in the nation by US News and World Report. Students apply through one of the 8 participating Georgia Tech home schools or departments and students are free to work with any of the 90+ participating program faculty members from the Colleges of Engineering, Computing, Sciences, and Architecture as well as Emory University School of Medicine. The BioE Graduate Program is one of the most innovative and integrative program available at Georgia Tech, giving the students the flexibility and creativity to pursue interdisciplinary research and create their own future.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Ranked 2nd in the nation by US News and World Report"}],"uid":"27224","created_gmt":"2012-08-25 19:17:25","changed_gmt":"2016-10-08 03:12:43","author":"Megan McDevitt","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2012-08-25T00:00:00-04:00","iso_date":"2012-08-25T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"149341":{"id":"149341","type":"image","title":"BioEngineering Video Image","body":null,"created":"1449178763","gmt_created":"2015-12-03 21:39:23","changed":"1475894782","gmt_changed":"2016-10-08 02:46:22","alt":"BioEngineering Video Image","file":{"fid":"195146","name":"bioe-forme.jpg","image_path":"\/sites\/default\/files\/images\/bioe-forme_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/bioe-forme_0.jpg","mime":"image\/jpeg","size":31101,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/bioe-forme_0.jpg?itok=2olwsaXM"}}},"media_ids":["149341"],"related_links":[{"url":"http:\/\/www.bioengineering.gatech.edu\/","title":"BioEngineering website"},{"url":"http:\/\/www.ibb.gatech.edu\/","title":"Petit Institute for Bioengineering and Bioscience"}],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[],"keywords":[{"id":"569","name":"bioengineering"},{"id":"249","name":"Biomedical Engineering"},{"id":"41681","name":"College of Engineering; Parker H. Petit Institute of Bioengineering and Biosciences; Andres Garcia"},{"id":"4896","name":"College of Sciences"},{"id":"41691","name":"Han Lu"},{"id":"10961","name":"julie champion"},{"id":"1924","name":"Robert Butera"},{"id":"167602","name":"SCEC Events"},{"id":"760","name":"Todd McDevitt"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"}],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:colly.mitchell@ibb.gatech.edu\u0022\u003EColly Mitchell\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003ESpecial Projects\u003C\/p\u003E\u003Cp\u003ECommunications, Marketing \u0026amp; Events\u003C\/p\u003E\u003Cp\u003EParker H. Petit Institute for Bioengineering \u0026amp; Bioscience\u003C\/p\u003E\u003Cp\u003EGeorgia Institute of Technology\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\u003Cp\u003E\u003Ca href=\u0022mailto:Chris%20Ruffin%20\u0026lt;chris.ruffin@ibb.gatech.edu\u0026gt;\u0022\u003EChris Ruffin\u003C\/a\u003E\u003C\/p\u003E\u003Cp class=\u0022p1\u0022\u003EAcademic Advisor\u003C\/p\u003E\u003Cp\u003EBioEngineering Graduate Program\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E","format":"limited_html"}],"email":["colly.mitchell@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"144931":{"#nid":"144931","#data":{"type":"news","title":"Third Class of Stem Cell Biomanufacturing IGERT Trainees Selected","body":[{"value":"\u003Cp\u003EThe National Science Foundation (NSF) funded Integrative Graduate Education and Research Traineeship (IGERT) program in Stem Cell Biomanufacturing announced its third class of Ph.D. student trainees. The five new graduate students come from a wide variety of disciplines including the School of Chemical and Biomolecular \u0026nbsp;Engineering, Wallace H. Coulter Department of Biomedical Engineering and George W. Woodruff School of Mechanical Engineering.\u003C\/p\u003E\u003Cp\u003E\u201cThis grant provides a unique training opportunity for top engineering graduate students looking to understand how to control stem cells into clinically relevant numbers,\u201d stated Todd McDevitt, PhD.\u003C\/p\u003E\u003Cp\u003EMcDevitt, associate professor in the Wallace H. Coulter Department of Biomedical Engineering is co-directing the IGERT program with Robert M. Nerem, professor emeritus of the George W. Woodruff School of Mechanical Engineering at Georgia Tech. \u0026nbsp;McDevitt is also director of the Stem Cell Engineering Center which administers this award.\u003C\/p\u003E\u003Cp\u003ERecently highlighted by Nature magazine as one of the \u201cout of the box\u201d manufacturing educational programs in the country, the $3 million NSF-funded IGERT was awarded to Georgia Tech in 2010 to educate and train the first generation of Ph.D. students in the translation and commercialization of stem cell technologies for diagnostic and therapeutic applications.\u003C\/p\u003E\u003Cp\u003EThe Stem Cell Biomanufacturing IGERT program supports new incoming Georgia Tech Ph.D. students for their first two years of graduate school. The program offers a core curriculum in stem cell engineering and bioprocessing coupled with elective tracks in advanced technologies, public policy, ethics or entrepreneurship.\u003C\/p\u003E\u003Cp\u003E\u201cThe current state of the field of stem cell research offers a unique opportunity for engineers to contribute significantly to the generation of robust, reproducible and scalable methods for phenotypic characterization, propagation, differentiation and bioprocessing of stem cells,\u201d McDevitt added.\u003C\/p\u003E\u003Cp\u003ETrainees are afforded opportunities to meet with leading experts in the field who visit as part of the Stem Cell Engineering seminar series, attend the annual stem cell engineering workshop, participate in outreach activities and interact with representatives from leading companies during Georgia Tech\u2019s annual Bio Industry Symposium.\u003C\/p\u003E\u003Cp\u003EGeorgia Tech\u0027s Stem Cell Biomanufacturing IGERT award will support at least 30 graduate students over the 5 years of the award.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cbr \/\u003E2012 Trainees \u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EOlivia Burnsed - Wallace H. Coulter Department of Biomedical Engineering\u003C\/p\u003E\u003Cp\u003EEfrain Cermeno - Wallace H. Coulter Department of Biomedical Engineering\u003C\/p\u003E\u003Cp\u003EAlbert Cheng - Wallace H. Coulter Department of Biomedical Engineering\u003C\/p\u003E\u003Cp\u003EJose Garcia - George W. Woodruff School of Mechanical Engineering\u003C\/p\u003E\u003Cp\u003EEmily Jackson - School of Chemical and Biomolecular Engineering\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cbr \/\u003E\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E2011 Trainees \u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003ETom Bongiorno \u2013 George W. Woodruff School of Mechanical Engineering\u003C\/p\u003E\u003Cp\u003ERob Dromms \u2013 School of Chemical and Biomolecular Engineering\u003C\/p\u003E\u003Cp\u003EDevon Headen \u2013 Wallace H. Coulter Department of Biomedical Engineering\u003C\/p\u003E\u003Cp\u003EGreg Holst \u2013 George W. Woodruff School of Mechanical Engineering\u003C\/p\u003E\u003Cp\u003ETorri Rinker \u2013 Wallace H. Coulter Department of Biomedical Engineering\u003C\/p\u003E\u003Cp\u003EShalini Saxena \u2013 School of Material Science \u0026amp; Engineering\u003C\/p\u003E\u003Cp\u003EJosh Zimmerman \u2013 Wallace H. Coulter Department of Biomedical Engineering\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cbr \/\u003E 2010 Trainees\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EAmy Cheng \u2013 George W. Woodruff School of Mechanical Engineering\u003C\/p\u003E\u003Cp\u003EAlison Douglas \u2013 Wallace H. Coulter Department of Biomedical Engineering\u003C\/p\u003E\u003Cp\u003EJennifer Lei \u2013 George W. Woodruff School of Mechanical Engineering\u003C\/p\u003E\u003Cp\u003EDouglas White \u2013 Wallace H. Coulter Department of Biomedical Engineering\u003C\/p\u003E\u003Cp\u003EJenna Wilson \u2013 Wallace H. Coulter Department of Biomedical Engineering\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"The National Science Foundation (NSF) funded Integrative Graduate Education and Research Traineeship (IGERT) program in Stem Cell Biomanufacturing announced its third class of Ph.D. student trainees."}],"field_summary":[{"value":"\u003Cp\u003EThe National Science Foundation (NSF) funded Integrative Graduate Education and Research Traineeship (IGERT) program in Stem Cell Biomanufacturing announced its third class of Ph.D. student trainees.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"The National Science Foundation (NSF) funded Integrative Graduate Education and Research Traineeship (IGERT) program in Stem Cell Biomanufacturing announced its third class of Ph.D. student trainees."}],"uid":"27224","created_gmt":"2012-08-08 10:07:36","changed_gmt":"2016-10-08 03:12:40","author":"Megan McDevitt","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2012-08-08T00:00:00-04:00","iso_date":"2012-08-08T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"71676":{"id":"71676","type":"image","title":"IGERT Trainees with NSF Director, Subra Suresh, PhD","body":null,"created":"1449177396","gmt_created":"2015-12-03 21:16:36","changed":"1475894642","gmt_changed":"2016-10-08 02:44:02","alt":"IGERT Trainees with NSF Director, Subra Suresh, PhD","file":{"fid":"193554","name":"nsf_pres_igert_trainees_0.jpg","image_path":"\/sites\/default\/files\/images\/nsf_pres_igert_trainees_0_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/nsf_pres_igert_trainees_0_0.jpg","mime":"image\/jpeg","size":7206,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/nsf_pres_igert_trainees_0_0.jpg?itok=QXNbopyx"}},"71716":{"id":"71716","type":"image","title":"Stem Cell Biomanufacturing IGERT 2011 Trainee Class","body":null,"created":"1449177396","gmt_created":"2015-12-03 21:16:36","changed":"1475894642","gmt_changed":"2016-10-08 02:44:02","alt":"Stem Cell Biomanufacturing IGERT 2011 Trainee Class","file":{"fid":"193558","name":"igert_group_photo_fall_2011.jpg","image_path":"\/sites\/default\/files\/images\/igert_group_photo_fall_2011_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/igert_group_photo_fall_2011_0.jpg","mime":"image\/jpeg","size":116688,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/igert_group_photo_fall_2011_0.jpg?itok=7213Zx-M"}}},"media_ids":["71676","71716"],"related_links":[{"url":"http:\/\/www.stemcelligert.gatech.edu\/","title":"Stem Cell Biomanufacturing IGERT"},{"url":"http:\/\/ibb.gatech.edu\/","title":"Parker H. Petit Institute for Bioengineering and Bioscience"}],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[],"keywords":[{"id":"594","name":"college of engineering"},{"id":"10506","name":"IGERT"},{"id":"497","name":"Parker H. Petit Institute for Bioengineering and Bioscience"},{"id":"540","name":"Robert M. Nerem"},{"id":"167603","name":"Stem Cell Engineering"},{"id":"760","name":"Todd McDevitt"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:mcdevitt@ibb.gatech.edu\u0022 target=\u0022_blank\u0022\u003EMegan McDevitt\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003EMarketing Communications Director\u003Cbr \/\u003EParker H. Petit Institute for Bioengineering \u0026amp; Bioscience\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E","format":"limited_html"}],"email":["mcdevitt@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"129881":{"#nid":"129881","#data":{"type":"news","title":"Successful Stem Cell Differentiation Requires DNA Compaction, Study Finds","body":[{"value":"\u003Cp\u003ENew research findings show that embryonic stem cells unable to fully compact the DNA inside them cannot complete their primary task: differentiation into specific cell types that give rise to the various types of tissues and structures in the body.\u003C\/p\u003E\u003Cp\u003EResearchers from the Georgia Institute of Technology and Emory University found that chromatin compaction is required for proper embryonic stem cell differentiation to occur. Chromatin, which is composed of histone proteins and DNA, packages DNA into a smaller volume so that it fits inside a cell.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003EA study published on May 10, 2012 in the journal \u003Cem\u003E\u003Ca href=\u0022http:\/\/dx.doi.org\/10.1371\/journal.pgen.1002691\u0022\u003EPLoS Genetics\u003C\/a\u003E\u003C\/em\u003E found that embryonic stem cells lacking several histone H1 subtypes and exhibiting reduced chromatin compaction suffered from impaired differentiation under multiple scenarios and demonstrated inefficiency in silencing genes that must be suppressed to induce differentiation.\u003C\/p\u003E\u003Cp\u003E\u201cWhile researchers have observed that embryonic stem cells exhibit a relaxed, open chromatin structure and differentiated cells exhibit a compact chromatin structure, our study is the first to show that this compaction is not a mere consequence of the differentiation process but is instead a necessity for differentiation to proceed normally,\u201d said \u003Ca href=\u0022http:\/\/www.biology.gatech.edu\/people\/yuhong-fan\/?id=yuhong-fan\u0022\u003EYuhong Fan\u003C\/a\u003E, an assistant professor in the \u003Ca href=\u0022http:\/\/www.biology.gatech.edu\/\u0022\u003EGeorgia Tech School of Biology\u003C\/a\u003E.\u003C\/p\u003E\u003Cp\u003EFan and \u003Ca href=\u0022http:\/\/www.bme.gatech.edu\/facultystaff\/faculty_record.php?id=78\u0022\u003ETodd McDevitt\u003C\/a\u003E, an associate professor in the \u003Ca href=\u0022http:\/\/www.bme.gatech.edu\/\u0022\u003EWallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University\u003C\/a\u003E, led the study with assistance from Georgia Tech graduate students Yunzhe Zhang and Kaixiang Cao, research technician Marissa Cooke, and postdoctoral fellow Shiraj Panjwani.\u003C\/p\u003E\u003Cp\u003EThe work was supported by the National Institutes of Health\u2019s National Institute of General Medical Sciences (NIGMS), the National Science Foundation, a Georgia Cancer Coalition Distinguished Scholar Award, and a Johnson \u0026amp; Johnson\/Georgia Tech Healthcare Innovation Award.\u003C\/p\u003E\u003Cp\u003ETo investigate the impact of linker histones and chromatin folding on stem cell differentiation, the researchers used embryonic stem cells that lacked three subtypes of linker histone H1 -- H1c, H1d and H1e -- which is the structural protein that facilitates the folding of chromatin into a higher-order structure. They found that the expression levels of these H1 subtypes increased during embryonic stem cell differentiation, and embryonic stem cells lacking these H1s resisted spontaneous differentiation for a prolonged time, showed impairment during embryoid body differentiation and were unsuccessful in forming a high-quality network of neural cells.\u003C\/p\u003E\u003Cp\u003E\u201cThis study has uncovered a new, regulatory function for histone H1, a protein known mostly for its role as a structural component of chromosomes,\u201d said Anthony Carter, who oversees epigenetics grants at NIGMS.\u0026nbsp; \u201cBy showing that H1 plays a part in controlling genes that direct embryonic stem cell differentiation, the study expands our understanding of H1\u2019s function and offers valuable new insights into the cellular processes that induce stem cells to change into specific cell types.\u201d\u003C\/p\u003E\u003Cp\u003EDuring spontaneous differentiation, the majority of the H1 triple-knockout embryonic stem cells studied by the researchers retained a tightly packed colony structure typical of undifferentiated cells and expressed high levels of Oct4 for a prolonged time. Oct4 is a pluripotency gene that maintains an embryonic stem cell\u2019s ability to self-renew and must be suppressed to induce differentiation.\u003C\/p\u003E\u003Cp\u003E\u201cH1 depletion impaired the suppression of the Oct4 and Nanog pluripotency genes, suggesting a novel mechanistic link by which H1 and chromatin compaction may mediate pluripotent stem cell differentiation by contributing to the epigenetic silencing of pluripotency genes,\u201d explained Fan. \u201cWhile a significant reduction in H1 levels does not interfere with embryonic stem cell self-renewal, it appears to impair differentiation.\u201d\u003C\/p\u003E\u003Cp\u003EThe researchers also used a rotary suspension culture method developed by McDevitt to produce with high efficiency homogonous 3D clumps of embryonic stem cells called embryoid bodies. Embryoid bodies typically contain cell types from all three germ layers -- the ectoderm, mesoderm and endoderm -- that give rise to the various types of tissues and structures in the body. However, the majority of the H1 triple-knockout embryoid bodies formed in rotary suspension culture lacked differentiated structures and displayed gene expression signatures characteristic of undifferentiated stem cells.\u003C\/p\u003E\u003Cp\u003E\u201cH1 triple-knockout embryoid bodies displayed a reduced level of activation of many developmental genes and markers in rotary culture, suggesting that differentiation to all three germ layers was affected.\u201d noted McDevitt. \u0026nbsp;\u003C\/p\u003E\u003Cp\u003EThe embryoid bodies also lacked the epigentic changes at the pluripotency genes necessary for differentiation, according to Fan.\u003C\/p\u003E\u003Cp\u003E\u201cWhen we added one of the deleted H1 subtypes to the embryoid bodies, Oct4 was suppressed normally and embryoid body differentiation continued,\u201d explained Fan. \u201cThe epigenetic regulation of Oct4 expression by H1 was also evident in mouse embryos.\u201d\u003C\/p\u003E\u003Cp\u003EIn another experiment, the researchers provided an environment that would encourage embryonic stem cells to differentiate into neural cells. However, the H1 triple-knockout cells were defective in forming neuronal and glial cells and a neural network, which is essential for nervous system development. Only 10 percent of the H1 triple-knockout embryoid bodies formed neurites and they produced on average eight neurites each. In contrast, half of the normal embryoid bodies produced, on average, 18 neurites.\u003C\/p\u003E\u003Cp\u003EIn future work, the researchers plan to investigate whether controlling H1 histone levels can be used to influence the reprogramming of adult cells to obtain induced pluripotent stem cells, which are capable of differentiating into tissues in a way similar to embryonic stem cells.\u003C\/p\u003E\u003Cp\u003E\u003Cem\u003EResearch reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health (NIH) under award number GM085261 and the National Science Foundation under award number CBET-0939511. The content is solely the responsibility of the principal investigators and does not necessarily represent the official views of the NIH or NSF.\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EResearch News \u0026amp; Publications Office\u003Cbr \/\u003E Georgia Institute of Technology\u003Cbr \/\u003E 75 Fifth Street, N.W., Suite 314\u003Cbr \/\u003E Atlanta, Georgia 30308 USA\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EMedia Relations Contacts:\u003C\/strong\u003E Abby Robinson (abby@innovate.gatech.edu; 404-385-3364) or John Toon (jtoon@gatech.edu; 404-894-6986)\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EWriter: \u003C\/strong\u003EAbby Robinson\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003ENew research findings show that embryonic stem cells unable to fully compact the DNA inside them cannot complete their primary task: differentiation into specific cell types that give rise to the various types of tissues and structures in the body.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"New research findings show that embryonic stem cells unable to fully compact the DNA inside them cannot differentiate into specific cell types."}],"uid":"27206","created_gmt":"2012-05-10 18:24:11","changed_gmt":"2016-10-08 03:12:13","author":"Abby Vogel Robinson","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2012-05-10T00:00:00-04:00","iso_date":"2012-05-10T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"129851":{"id":"129851","type":"image","title":"Impaired embryoid body differentiation","body":null,"created":"1449178634","gmt_created":"2015-12-03 21:37:14","changed":"1475894754","gmt_changed":"2016-10-08 02:45:54","alt":"Impaired embryoid body differentiation","file":{"fid":"194630","name":"embryoid-body-impaired-differentiation_hires.jpg","image_path":"\/sites\/default\/files\/images\/embryoid-body-impaired-differentiation_hires_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/embryoid-body-impaired-differentiation_hires_0.jpg","mime":"image\/jpeg","size":223571,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/embryoid-body-impaired-differentiation_hires_0.jpg?itok=m40LQuyX"}},"129861":{"id":"129861","type":"image","title":"Stem cell neural differentiation impairment","body":null,"created":"1449178634","gmt_created":"2015-12-03 21:37:14","changed":"1475894754","gmt_changed":"2016-10-08 02:45:54","alt":"Stem cell neural differentiation impairment","file":{"fid":"194631","name":"neural-impairment_hires.jpg","image_path":"\/sites\/default\/files\/images\/neural-impairment_hires_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/neural-impairment_hires_0.jpg","mime":"image\/jpeg","size":75404,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/neural-impairment_hires_0.jpg?itok=ak_mMV4T"}},"129871":{"id":"129871","type":"image","title":"Embryonic stem cell neural impairment","body":null,"created":"1449178634","gmt_created":"2015-12-03 21:37:14","changed":"1475894754","gmt_changed":"2016-10-08 02:45:54","alt":"Embryonic stem cell neural impairment","file":{"fid":"194632","name":"neural-impairment2_hires.jpg","image_path":"\/sites\/default\/files\/images\/neural-impairment2_hires_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/neural-impairment2_hires_0.jpg","mime":"image\/jpeg","size":65712,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/neural-impairment2_hires_0.jpg?itok=tR_NU5YN"}}},"media_ids":["129851","129861","129871"],"groups":[{"id":"1188","name":"Research Horizons"}],"categories":[{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"135","name":"Research"}],"keywords":[{"id":"33241","name":"Chromatin"},{"id":"594","name":"college of engineering"},{"id":"4896","name":"College of Sciences"},{"id":"11533","name":"Department of Biomedical Engineering"},{"id":"13436","name":"embryoid bodies"},{"id":"33211","name":"Embryonic Stem Cell"},{"id":"33281","name":"Epigenetics"},{"id":"33221","name":"Histone"},{"id":"33231","name":"histone H1"},{"id":"33261","name":"linker histone h1"},{"id":"33251","name":"neural differentiation"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003EAbby Robinson\u003Cbr \/\u003E Research News and Publications\u003Cbr \/\u003E \u003Ca href=\u0022mailto:abby@innovate.gatech.edu\u0022\u003Eabby@innovate.gatech.edu\u003C\/a\u003E\u003Cbr \/\u003E 404-385-3364\u003C\/p\u003E","format":"limited_html"}],"email":[],"slides":[],"orientation":[],"userdata":""}},"130111":{"#nid":"130111","#data":{"type":"news","title":"IGERT Trainees Attend SBE 3rd International Conference on Stem Cell Engineering","body":[{"value":"\u003Cp\u003EJenna Wilson and Douglas White, second-year IGERT trainees, presented at the Society for Biological Engineering\u2019s 3rd International Conference on Stem Cell Engineering in April 2012. The meeting brought together engineers, biologists, and clinicians who are working on cellular therapies to accelerate progress towards designing the stem cell and its environment.\u003C\/p\u003E\u003Cp\u003EThis conference focused on the advancement of stem cell research and tissue engineering with regards to biology, tissue regeneration and development of cell-based therapies. These approaches are contributing to the development of applied efforts in stem cell biology and engineering that can combine to aid in the development of stem cell therapeutics and bioprocesses.\u003C\/p\u003E\u003Cp\u003EJenna presented on the microfluidic single-cell analysis of embryoid body heterogeneity. Her abstract detailed the need for single cell analysis techniques in order to assess heterogeneous cell types, particularly pluripotent stem cells. She has been developing a microfluidic approach to analyze the individual phenotypes of the cells from single EBs. Through her research, she has found that the use of a microfluidic device can provide a better evaluation on the efficacy and efficiency of directed differentiation methods by parsing out single cell dynamics from broad population-based information.\u003C\/p\u003E\u003Cp\u003EDoug presented on his development of a computational model which can predict phenotypic changes of embryonic stem cells (ESCs) in 3-D embryoid bodies. His research objective is to utilize rules based spatial and cellular modeling to provide insight into the underlying mechanisms governing cell fate transitions in 3-dimensional microenvironments experienced by pluripotent stem cells. Through his research, he has found that the state transition between pluripotency is largely modulated by local regulatory networks.\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"The Society for Biological Engineering and the International Society for Stem Cell Research partner for the 3rd International Conference on Stem Cell Engineering"}],"field_summary":[{"value":"\u003Cp\u003EIGERT trainees, Doug White \u0026amp; Jenna Wilson presented at the SBE\u0027s 3rd International Stem Cell Engineering Conference in Seattle, WA on April 29th - May 2nd.\u0026nbsp;\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"IGERT trainees Doug White \u0026 Jenna Wilson presented at Stem Cell Engineering Conference"}],"uid":"27487","created_gmt":"2012-05-11 15:31:20","changed_gmt":"2016-10-08 03:12:13","author":"Megan Richards","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2012-04-29T00:00:00-04:00","iso_date":"2012-04-29T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"130121":{"id":"130121","type":"image","title":"IGERT Trainees Attend SBE 3rd International Conference on Stem Cell Engineering","body":null,"created":"1449178634","gmt_created":"2015-12-03 21:37:14","changed":"1475894757","gmt_changed":"2016-10-08 02:45:57","alt":"IGERT Trainees Attend SBE 3rd International Conference on Stem Cell Engineering","file":{"fid":"194642","name":"sbe.jpg","image_path":"\/sites\/default\/files\/images\/sbe_1.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/sbe_1.jpg","mime":"image\/jpeg","size":78705,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/sbe_1.jpg?itok=p84RDk31"}}},"media_ids":["130121"],"related_links":[{"url":"http:\/\/stemcell.aiche.org\/","title":"SBE\u0027s 3rd International Conference on Stem Cell Engineering"},{"url":"http:\/\/www.stemcelligert.gatech.edu\/","title":"Stem Cell Biomanufacturing IGERT"}],"groups":[],"categories":[],"keywords":[{"id":"33391","name":"Doug White"},{"id":"10506","name":"IGERT"},{"id":"33321","name":"Jenna Wilson"},{"id":"171204","name":"SBE"},{"id":"167603","name":"Stem Cell Engineering"},{"id":"760","name":"Todd McDevitt"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[],"email":["megan.richards@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"112651":{"#nid":"112651","#data":{"type":"news","title":"Two Georgia Tech Faculty Help to Define Emerging U.S Stem Cell Engineering Field through International Study","body":[{"value":"\u003Cp\u003ERobert M. Nerem, Ph.D., professor in mechanical engineering and Todd C.\nMcDevitt, Ph.D., director of the Stem Cell Engineering Center at Georgia Tech,\nwere invited by the lead sponsor, Semahat S.\nDemir Ph.D. of the National Science Foundation (NSF) to take part in an\ninternational assessment of the stem cell engineering field.\u0026nbsp; Nerem will\nlead the panel and the findings of this study will result in recommendations to\nthe NSF and other funding agencies on future research directions and\ninvestments, recommendations on global initiatives with international partners\nand public workshops.\u003Cbr \/\u003E\n\u003Cbr \/\u003E\nThe study, which is being conducted by the World Technology Evaluation Center\n(WTEC), aims to assess the current status and the trends of stem cell\nengineering, and compare U.S. research and development programs with those\nabroad.\u0026nbsp; In addition to the NSF, the study is co-sponsored by the National\nInstitutes of Health (NIH) and the National Institute of Standards and\nTechnology (NIST).\u003Cbr \/\u003E\n\u003Cbr \/\u003E\n\u201cTech is fortunate to have two out of the six experts on this panel,\u201d Nerem\nsaid. \u201cIt conveys Georgia Tech\u0027s nascent leadership in this relatively new and\nrapidly growing field and it is a great opportunity to provide input and\nleadership to our funding agencies and help our government understand where\nbest to invest.\u201d\u003Cbr \/\u003E\n\u003Cbr \/\u003E\nPresident Obama, Congress and numerous states have recognized the value of stem\ncell research. Knowledge of research activities abroad will help to formulate\nand prioritize research directions to support President Obama\u0027s executive order\nfor expanding stem cell research so that it has the greatest potential for\nclinical and commercial applications.\u003Cbr \/\u003E\n\u003Cbr \/\u003E\nDozens of companies have recently entered the stem cell engineering field in\nsearch of clinical and commercial applications.\u0026nbsp; There is clear impetus\nfor the U.S. to support stem cell research and continue its leadership in the\nbasic sciences for the betterment of humankind.\u0026nbsp; A Congressional Research\nService report on stem cell research, which reviewed the political, moral and\nethical issues of the subject, indicated the strengthening interest and\neconomic commitment for stem cell research in the U.S. and the rest of the\nworld.\u003Cbr \/\u003E\n\u003Cbr \/\u003E\nThis study will use WTEC\u0027s methodology and an expert panel of six to conduct\nsite visits to overseas laboratories where work in stem cell engineering is\ndone. The panelists began their study in November, when they traveled to China\nand Japan, and will continue their evaluation this week in Europe.\u0026nbsp; These\nvisits, combined with the panel\u0027s own research experiences and assessments,\nwill help shape a report.\u0026nbsp; Like the previous WTEC studies on the tissue\nengineering and nanotechnology fields, this effort will act as a guide for U.S.\nresearch investments in this emerging field and will help identify key issues\nof critical importance to program officers. \u2028\u003Cbr \/\u003E\n\u003Cbr \/\u003E\n\u201cThis is an excellent opportunity to learn what other countries are doing and\nbenchmark against other programs in order to position the U.S. to become\nleaders in stem cell research and development,\u201d said McDevitt, who is also an\nassociate professor in the Wallace H. Counter Department of Biomedical\nEngineering at Georgia Tech and Emory University. \u201cManufacturing, clinical\ntrials and commercializing stem cell-based products, if done strategically, is\nsomething that could boost our nation\u2019s economy.\u201d \u003Cbr \/\u003E\n\u003Cbr \/\u003E\nThis week the scientists will travel to Denmark, France, Germany, Sweden and Switzerland. In addition to Nerem and McDevitt, other panelists include Jeanne\nLoring, Ph.D., The Scripps Institute; Sean Palecek, Ph.D., University of\nWisconsin; David Schaffer, Ph.D., University California at Berkeley; and Peter\nZandstra, Ph.D., University of Toronto.\u003Cbr \/\u003E\n\u003Cbr \/\u003E\nWTEC is a non-profit 501(c)(3) research institute, which is a spin-off of\nLoyola University Maryland.\u0026nbsp; Since 1989, WTEC has provided such assessment\nstudies in more than 60 fields of R\u0026amp;D under peer-reviewed grants from NSF.\u003C\/p\u003E\n\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Georgia Tech faculty invited by the National Science Foundation to take part in an international assessment of the Stem Cell Engineering field."}],"field_summary":[{"value":"\u003Cp\u003ERobert M. Nerem, Ph.D., professor in mechanical engineering and Todd C.\nMcDevitt, Ph.D., director of the Stem Cell Engineering Center at Georgia Tech,\nwere invited by the lead sponsor, Semahat S.\nDemir Ph.D. from the National Science Foundation (NSF) to take part in an\ninternational assessment of the stem cell engineering field.\u0026nbsp; Nerem will\nlead the panel and the findings of this study will result in recommendations to\nthe NSF and other funding agencies on future research directions and\ninvestments, recommendations on global initiatives with international partners\nand public workshops.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Georgia Tech faculty invited by the National Science Foundation to take part in an international assessment of the Stem Cell Engineering field."}],"uid":"27224","created_gmt":"2012-02-27 16:16:04","changed_gmt":"2016-10-08 03:11:44","author":"Megan McDevitt","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2012-03-01T00:00:00-05:00","iso_date":"2012-03-01T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"60434":{"id":"60434","type":"image","title":"Robert Nerem \u0026 Todd McDevitt","body":null,"created":"1449176267","gmt_created":"2015-12-03 20:57:47","changed":"1475894523","gmt_changed":"2016-10-08 02:42:03","alt":"Robert Nerem \u0026 Todd McDevitt","file":{"fid":"191125","name":"tpb17928.jpg","image_path":"\/sites\/default\/files\/images\/tpb17928_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tpb17928_0.jpg","mime":"image\/jpeg","size":1599704,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tpb17928_0.jpg?itok=qHDHZJYj"}},"70893":{"id":"70893","type":"image","title":"Robert Nerem","body":null,"created":"1449177328","gmt_created":"2015-12-03 21:15:28","changed":"1475894625","gmt_changed":"2016-10-08 02:43:45"},"70131":{"id":"70131","type":"image","title":"Todd McDevitt","body":null,"created":"1449177288","gmt_created":"2015-12-03 21:14:48","changed":"1475894616","gmt_changed":"2016-10-08 02:43:36"}},"media_ids":["60434","70893","70131"],"related_links":[{"url":"http:\/\/www.wtec.org\/SCE\/","title":"Study website"},{"url":"http:\/\/scec.gatech.edu\/","title":"Stem Cell Engineering Center"},{"url":"http:\/\/www.nsf.gov\/","title":"National Science Foundation"},{"url":"http:\/\/www.nist.gov\/index.html","title":"National Institute of Standards and Technology"}],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"129","name":"Institute and Campus"},{"id":"132","name":"Institute Leadership"}],"keywords":[{"id":"215","name":"manufacturing"},{"id":"362","name":"National Science Foundation"},{"id":"3414","name":"Robert Nerem"},{"id":"167490","name":"SCEC"},{"id":"167603","name":"Stem Cell Engineering"},{"id":"760","name":"Todd McDevitt"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:colly.mitchell@ibb.gatech.edu\u0022\u003EColly Mitchell\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003EMarketing \u0026amp; Events\u003Cbr \/\u003EParker H. Petit Institute for Bioengineering and Bioscience\u003Cbr \/\u003EGeorgia Institute of Technology\u003C\/p\u003E","format":"limited_html"}],"email":["colly.mitchell@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"74084":{"#nid":"74084","#data":{"type":"news","title":"Survey Reveals Scientists Have Trouble Accessing Human Embryonic Stem Cell Lines","body":[{"value":"\u003Cp\u003EThe promise of stem cell research for drug discovery and cell-based therapies depends on the ability of scientists to acquire stem cell lines for their research. \u003C\/p\u003E\u003Cp\u003EA survey of more than 200 human embryonic stem cell researchers in the United States found that nearly four in ten researchers have faced excessive delay in acquiring a human embryonic stem cell line and that more than one-quarter were unable to acquire a line they wanted to study. \u003C\/p\u003E\u003Cp\u003E\u0022The survey results provide empirical data to support previously anecdotal concerns that delays in acquiring or an inability to acquire certain human embryonic stem cell lines may be hindering stem cell science in the United States,\u0022 said Aaron Levine, an assistant professor in the School of Public Policy in the Ivan Allen College of Liberal Arts at the Georgia Institute of Technology. \u003C\/p\u003E\u003Cp\u003EResults of the survey were published in the December issue of the journal \u003Cem\u003ENature Biotechnology\u003C\/em\u003E. Funding for the study was provided by the Kauffman Foundation\u0027s Roadmap for an Entrepreneurial Economy Program. \u003C\/p\u003E\u003Cp\u003ELevine administered the web-based survey in November 2010 to more than 1,400 stem cell scientists working at U.S. academic and non-profit medical research institutions. Almost 400 respondents from 32 states completed the survey. Of those, 205 respondents reported using human embryonic stem cells in their research, and their responses were used in this study. \u003C\/p\u003E\u003Cp\u003EThe surveyed scientists cited four main reasons for their problems accessing human embryonic stem cell lines: difficulty obtaining material transfer agreements, failure to acquire research approval from internal institutional oversight committees, cell line owners that were unwilling to share and federal policy considerations. \u003C\/p\u003E\u003Cp\u003E\u0022Bureaucratic challenges may be inevitable in this ethically contentious and politically sensitive field, but policymakers should attempt to mitigate these issues by doing things like encouraging institutions to accept third-party ownership verification and providing clearer guidance on human embryonic stem cell research not eligible for federal funding,\u0022 said Levine, who is also a member of the Georgia Tech Institute for Bioengineering and Bioscience. \u003C\/p\u003E\u003Cp\u003EThe broad patents assigned to the initial inventors of the method used to isolate embryonic stem cells and numerous narrower patents claiming specific human embryonic stem cell-related techniques are also factors complicating access to human embryonic stem cell lines, according to Levine. \u003C\/p\u003E\u003Cp\u003EWhen survey respondents were asked how many of the more than 1,000 existing human embryonic stem cell lines they used, 76 percent reported using three or fewer lines and 54 percent reported using two or fewer lines in their research. More than half of the 130 respondents cited access issues as a major reason they chose to use specific cell lines in their research. \u003C\/p\u003E\u003Cp\u003E\u0022These results illustrate that many human embryonic stem cell scientists in the United States are not conducting comparative studies with a diverse set of human embryonic stem cell lines, which raises concern that at least some results are cell-line specific rather than broadly applicable,\u0022 said Levine. \u0022Federal and state funding agencies may want to consider encouraging research using multiple diverse human embryonic stem cell lines to improve the reliability of research results.\u0022 \u003C\/p\u003E\u003Cp\u003EEmbryonic stem cell lines are being used to develop new cellular therapies for various diseases, to screen for new drugs and to better understand inherited diseases. It\u0027s crucial that diverse lines are available for this research to ensure that all individuals benefit from the results. \u003C\/p\u003E\u003Cp\u003EWhile availability was cited as the most common factor affecting scientists\u0027 choices regarding which cell lines to use, other considerations included suitability for a specific project, familiarity with specific lines, a desire to reduce complications in the laboratory, cost, the extent of relevant literature and the preferences of scientists\u0027 colleagues. \u003C\/p\u003E\u003Cp\u003EThree of the initial human embryonic stem cell lines derived at the University of Wisconsin in the late 1990s were the lines most commonly used by respondents. Cell lines H1, H9 and H7 were used by 79, 68 and 26 percent of respondents, respectively. Scientists also reported using more than 100 other lines, but each of these was used by fewer than 12 percent of respondents. \u003C\/p\u003E\u003Cp\u003E\u0022Other research communities in the life sciences have experienced material access problems and they addressed them, in part, by creating centralized information and data sharing hubs, including public DNA sequence databases, tissue banks and mouse repositories. The stem cell research community has taken promising steps in this direction, but this analysis should encourage the community to continue and, if possible, accelerate these efforts,\u0022 added Levine. \u003C\/p\u003E\u003Cp\u003EArticle Written by Abby Robinson, Georgia Tech Research News \u0026amp; Publications Office\u003C\/p\u003E\u003Cp\u003ERelated Links\u003C\/p\u003E\u003Cul\u003E\u003Cli\u003E\u003Ca href=\u0022http:\/\/dx.doi.org\/10.1038\/nbt.2029\u0022\u003ENature Biotechnology paper\u003C\/a\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca href=\u0022http:\/\/www.spp.gatech.edu\/aboutus\/faculty\/AaronLevine\u0022\u003EAaron Levine\u003C\/a\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca href=\u0022http:\/\/www.spp.gatech.edu\/\u0022\u003ESchool of Public Policy\u003C\/a\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca href=\u0022http:\/\/www.ibb.gatech.edu\/\u0022\u003EInstitute for Bioengineering and Bioscience\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EThe promise of stem cell research for drug discovery and cell-based therapies depends on the ability of scientists to acquire stem cell lines for their research. \u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":"","uid":"27167","created_gmt":"2011-12-13 15:47:32","changed_gmt":"2016-10-08 03:10:50","author":"Rebecca Keane","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2011-12-12T00:00:00-05:00","iso_date":"2011-12-12T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"74085":{"id":"74085","type":"image","title":"Aaron Levine","body":null,"created":"1449178046","gmt_created":"2015-12-03 21:27:26","changed":"1475894686","gmt_changed":"2016-10-08 02:44:46","alt":"Aaron Levine","file":{"fid":"193765","name":"aaronlevine200x300wtboard.jpg","image_path":"\/sites\/default\/files\/images\/aaronlevine200x300wtboard_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/aaronlevine200x300wtboard_0.jpg","mime":"image\/jpeg","size":263264,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/aaronlevine200x300wtboard_0.jpg?itok=MWEYKxHs"}},"73880":{"id":"73880","type":"image","title":"Chart on difficulty","body":null,"created":"1449178028","gmt_created":"2015-12-03 21:27:08","changed":"1475894681","gmt_changed":"2016-10-08 02:44:41"},"73881":{"id":"73881","type":"image","title":"Chart on choosing stem cells","body":null,"created":"1449178028","gmt_created":"2015-12-03 21:27:08","changed":"1475894681","gmt_changed":"2016-10-08 02:44:41"}},"media_ids":["74085","73880","73881"],"groups":[{"id":"1281","name":"Ivan Allen College of Liberal Arts"}],"categories":[],"keywords":[{"id":"9555","name":"aaron levine"},{"id":"2548","name":"biomedical"},{"id":"167413","name":"Stem Cell"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003ERebecca Keane\u0026nbsp; 404-894-1720\u003C\/p\u003E","format":"limited_html"}],"email":["rebecca.keane@iac.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"71675":{"#nid":"71675","#data":{"type":"news","title":"Stem Cell Biomanufacturing NSF IGERT Announces 2nd Class of Trainees","body":[{"value":"\u003Cp\u003E\u0026nbsp;Georgia Tech\u2019s Stem Cell Biomanufacturing Integrated Graduate Education Research Training (IGERT) program, recently identified by Nature magazine as one of the \u201cout of the box\u201d manufacturing educational programs in the country, announced its second class of graduate students today.  The seven new trainees come from a wide variety of disciplines including the school of chemical and biomolecular engineering, biomedical engineering, mechanical engineering and material science and engineering.\n\n\u003C\/p\u003E\u003Cp\u003EThe $3 million NSF-funded IGERT was awarded to Georgia Tech in 2010 to educate and train the first generation of PhD students in the translation and commercialization of stem cell technologies for diagnostic and therapeutic applications. The current state of the field of stem cell research offers a unique opportunity for engineers to contribute significantly to the generation of robust, reproducible and scalable methods for phenotypic characterization, propagation, differentiation and bioprocessing of stem cells.\u003C\/p\u003E\u003Cp\u003EDirected by Co-Principal investigators, Todd C. McDevitt, PhD, associate professor in the Wallace H. Coulter Department of Biomedical Engineering, and Robert M. Nerem, PhD, professor emeritus in the George W. Woodruff School of Mechanical Engineering, this grant provides a unique training opportunity to top engineering graduate students looking to understand how to scale and control stem cells into clinically relevant numbers. The goal, to train the next generation of experts in this new field of stem cell biomanufacturing for the development of stem cell technologies, diagnostics, and therapies. \u003Cbr \/\u003E\u003C\/p\u003E\u003Cp\u003ECatalyzed by a surge of activity in the late 1990s, advances in stem cell biology over the past decade have continued to accelerate at a rapid pace.  The manufacturing industry is expanding with commercial development of stem cell products projected to be $10 billion within the next 6-8 years.  Moreover, the transformation from discoveries in stem cell biology to viable cellular technologies has enormous promise to revolutionize a range of applications for many aspects of society. As a result, stem cell biomanufacturing is on the verge of broadly impacting regenerative medicine, drug discovery and development, cell-based diagnostics and cancer.\n\n\u003Cbr \/\u003E\u003C\/p\u003E\u003Cp\u003EEarlier this year, United States President Barack Obama asked Georgia Tech\u2019s President G.P. \u201cBud\u201d Peterson to join the Advanced Manufacturing Partnership steering committee to revolutionize manufacturing in the United States.  Along with other industry and university representatives, the purpose of this committee is to identify and invest in the key emerging technologies, such as information technology, biotechnology and nanotechnology to help U.S. manufacturers improve cost, quality and speed of production in order to remain globally competitive.  The stem cell biomanufacturing industry need look no further than President Peterson\u2019s backyard for future experts in stem cell biomanufacturing.\n\u003Cbr \/\u003E\u003C\/p\u003E\u003Cp\u003E\u201cI have received dozens of calls and emails from industry looking for graduates of this program because of the uniqueness of the training and the need for manufacturing expertise,\u201d stated McDevitt. \u201cGeorgia Tech has a real opportunity to become a leader in this emerging field and begin to answer questions about down-stream processes so that when the first clinical therapies are discovered, scientists are prepared to be able to respond with cells in the quantity and quality that will be needed for treatment.\u201d\n\n\u003C\/p\u003E\u003Cp\u003EThe Stem Cell Biomanufacturing IGERT is further catalyzed by the Stem Cell Engineering Center, which was also established in 2010 and brings together research laboratories from all over the state of Georgia to discuss and develop collaborative opportunities for research labs engineering novel stem cell based technologies, therapies, and diagnostics.   \u003C\/p\u003E\u003Cp\u003EGeorgia Tech\u0027s Stem Cell Biomanufacturing IGERT award will train over 30 graduate students in the first 5 years of the program. The IGERT offers a core curriculum in stem cell engineering and analytical design processes coupled with elective tracks in advanced technologies, public policy, ethics or entrepreneurship. \u003Cbr \/\u003E\u003Cbr \/\u003E\u003Cstrong\u003E\u003C\/strong\u003E\n\u003Cstrong\u003E2011 Trainees\u0026nbsp;\u003C\/strong\u003E\u003Cbr \/\u003ETom Bongiorno \u2013 George W. Woodruff School of Mechanical Engineering, Advisor \u2013 Todd Sulchek\n\u003Cbr \/\u003ERob Dromms \u2013 School of Chemical and Biomolecular Engineering, Advisor \u2013 Mark Styczynski\u003Cbr \/\u003EDevon Headen \u2013 Wallace H. Coulter Department of Biomedical Engineering, Advisor \u2013 Andres Garcia\n\u003Cbr \/\u003EGreg Holst \u2013 George W. Woodruff School of Mechanical Engineering, Advisor \u2013 Craig Forest\n\u003Cbr \/\u003ETorri Rinker \u2013 Wallace H. Coulter Department of Biomedical Engineering, Advisor \u2013 Johnna Temenoff\n\u003Cbr \/\u003EShalini Saxena \u2013 School of Material Science \u0026amp; Engineering, Advisor \u2013 Andrew Lyon\u003Cbr \/\u003EJosh Zimmerman \u2013 Wallace H. Coulter Department of Biomedical Engineering, Advisor \u2013 Todd McDevitt\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E2010 Trainees \u003C\/strong\u003E\u003Cbr \/\u003EAmy Cheng \u2013 George W. Woodruff School of Mechanical Engineering, Advisor \u2013 Andr\u00e9s Garc\u00eda\u003Cbr \/\u003EAlison Douglas \u2013 Wallace H. Coulter Department of Biomedical Engineering, Advisor \u2013 Thomas Barker \u003Cbr \/\u003EJennifer Lei \u2013 George W. Woodruff School of Mechanical Engineering, Advisor \u2013 Johnna Temenoff \u003Cbr \/\u003EDouglas White \u2013 Wallace H. Coulter Department of Biomedical Engineering, Advisors \u2013 Melissa Kemp \u0026amp; Todd McDevitt \u003Cbr \/\u003EJenna Wilson \u2013 Wallace H. Coulter Department of Biomedical Engineering, Advisor \u2013 Todd McDevitt\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Seven new graduate students to begin training in manufacturing stem cells"}],"field_summary":[{"value":"\u003Cp\u003EStem Cell Biomanufacturing NSF IGERT Announces 2nd Class. \u0026nbsp;Seven new graduate students to begin training in manufacturing stem cells.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Seven new graduate students to begin training in manufacturing stem cells"}],"uid":"27195","created_gmt":"2011-10-21 13:35:34","changed_gmt":"2016-10-08 03:10:34","author":"Colly Mitchell","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2011-10-24T00:00:00-04:00","iso_date":"2011-10-24T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"71716":{"id":"71716","type":"image","title":"Stem Cell Biomanufacturing IGERT 2011 Trainee Class","body":null,"created":"1449177396","gmt_created":"2015-12-03 21:16:36","changed":"1475894642","gmt_changed":"2016-10-08 02:44:02","alt":"Stem Cell Biomanufacturing IGERT 2011 Trainee Class","file":{"fid":"193558","name":"igert_group_photo_fall_2011.jpg","image_path":"\/sites\/default\/files\/images\/igert_group_photo_fall_2011_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/igert_group_photo_fall_2011_0.jpg","mime":"image\/jpeg","size":116688,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/igert_group_photo_fall_2011_0.jpg?itok=7213Zx-M"}},"71676":{"id":"71676","type":"image","title":"IGERT Trainees with NSF Director, Subra Suresh, PhD","body":null,"created":"1449177396","gmt_created":"2015-12-03 21:16:36","changed":"1475894642","gmt_changed":"2016-10-08 02:44:02","alt":"IGERT Trainees with NSF Director, Subra Suresh, PhD","file":{"fid":"193554","name":"nsf_pres_igert_trainees_0.jpg","image_path":"\/sites\/default\/files\/images\/nsf_pres_igert_trainees_0_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/nsf_pres_igert_trainees_0_0.jpg","mime":"image\/jpeg","size":7206,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/nsf_pres_igert_trainees_0_0.jpg?itok=QXNbopyx"}},"71761":{"id":"71761","type":"image","title":"QR code stem cell IGERT","body":null,"created":"1449177405","gmt_created":"2015-12-03 21:16:45","changed":"1475894642","gmt_changed":"2016-10-08 02:44:02","alt":"QR code stem cell IGERT","file":{"fid":"193596","name":"stemcelligert.png","image_path":"\/sites\/default\/files\/images\/stemcelligert_0.png","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/stemcelligert_0.png","mime":"image\/png","size":330,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/stemcelligert_0.png?itok=hOYnMKH2"}}},"media_ids":["71716","71676","71761"],"related_links":[{"url":"http:\/\/stemcelligert.gatech.edu\/","title":"Stem Cell Biomanufacturing IGERT"},{"url":"http:\/\/scec.gatech.edu\/","title":"Stem Cell Engineering Center"},{"url":"http:\/\/www.ibb.gatech.edu\/","title":"Petit Institute for Bioengineering and Bioscience"},{"url":"http:\/\/gtresearchnews.gatech.edu\/stem-cell-biomanufacturing\/","title":"Scaling Up: NSF Awards Stem Cell Biomanufacturing IGERT"}],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"132","name":"Institute Leadership"},{"id":"141","name":"Chemistry and Chemical Engineering"},{"id":"134","name":"Student and Faculty"},{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"}],"keywords":[{"id":"14854","name":"biomanufacturing"},{"id":"10506","name":"IGERT"},{"id":"215","name":"manufacturing"},{"id":"3414","name":"Robert Nerem"},{"id":"167603","name":"Stem Cell Engineering"},{"id":"167130","name":"Stem Cells"},{"id":"760","name":"Todd McDevitt"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:megan.richards@ibb.gatech.edu\u0022 target=\u0022_blank\u0022\u003EMegan Richards\u003C\/a\u003E\u003Cbr \/\u003EProgram Coordinator\u003Cbr \/\u003EStem Cell Biomanufacturing IGERT\u003Cbr \/\u003EGeorgia Institute of Technology\u003Cbr \/\u003E404-385-0783\u0026nbsp;\u003C\/p\u003E","format":"limited_html"}],"email":["megan.richards@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"70374":{"#nid":"70374","#data":{"type":"news","title":"Stem Cell Biomanufacturing IGERT Trainees Meet the Director of the NSF","body":[{"value":"\u003Cp\u003ESubra Suresh, PhD, Director of the National Science Foundation (NSF), came to Georgia Tech to deliver the Parker H. Petit Institute\u2019s 2011 Distinguished Lecture presentation on diagnosing human diseases using biomedical models. While here, Suresh met with Georgia Tech\u0027s Stem Cell Biomanufacturing IGERT trainees. \u003Cbr \/\u003E\u003Cbr \/\u003EThe NSF awarded the Stem Cell Biomanufacturing IGERT in 2010 to Robert Nerem, PhD, director of the Georgia Tech \u0026amp; Emory Center for Regenerative Medicine, and Todd McDevitt, PhD, director of the Stem Cell Engineering Center and associate professor in the Wallace H. Coulter Department of Biomedical Engineering. \u003Cbr \/\u003E\u003Cbr \/\u003EThese IGERT graduates are conducting the highest quality stem cell research for the purposes of discovering stem cell therapies, technologies and diagnosis. From various engineering and scientific backgrounds, these students are working to enhance the fields of regenerative medicine, drug discovery \u0026amp; development, cell-based diagnostics and cancer treatments using stem cell applications. \u003Cbr \/\u003E\u003Cbr \/\u003EFall 2011 awards were given out to the following first-year PhD graduate students:\u003Cbr \/\u003E\u003Cbr \/\u003E\u003Cstrong\u003ETom Bongiorno\u003C\/strong\u003E\u0026nbsp; - Sulchek laboratory, School of Mechanical Engineering\u003Cbr \/\u003E\u003Cstrong\u003ERob Dromms\u003C\/strong\u003E - Styczynski laboratory, School of Chemical and Biomolecular Engineering\u003Cbr \/\u003E\u003Cstrong\u003EDevon Headen\u003C\/strong\u003E -\u0026nbsp; Garcia laboratory, Wallace H. Coulter Department of Biomedical Engineering\u003Cbr \/\u003E\u003Cstrong\u003EGreg Holst\u003C\/strong\u003E -\u0026nbsp; Precision Biosystems laboratory, School of Mechanical Engineering\u003Cbr \/\u003E\u003Cstrong\u003ETorri Rinker \u003C\/strong\u003E-\u0026nbsp; Temenoff laboratory, Wallace H. Coulter Department of Biomedical Engineering \u003Cbr \/\u003E\u003Cstrong\u003EShalini Saxena \u003C\/strong\u003E-\u0026nbsp; Lyon laboratory, School of Material Science Engineering\u003Cbr \/\u003E\u003Cstrong\u003EJosh Zimmermann \u003C\/strong\u003E-\u0026nbsp; McDevitt laboratory, Wallace H. Coulter Department of Biomedical Engineering\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":"","field_summary_sentence":[{"value":"Director of the NSF met with Georgia Tech\u0027s Stem Cell Biomanufacturing IGERT trainees for the Parker H. Petit Institute\u2019s 2011 Distinguished Lecture presentation."}],"uid":"27487","created_gmt":"2011-09-28 16:14:20","changed_gmt":"2016-10-08 03:10:14","author":"Megan Richards","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2011-09-28T00:00:00-04:00","iso_date":"2011-09-28T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"70375":{"id":"70375","type":"image","title":"IGERT Trainees with NSF Director","body":null,"created":"1449177314","gmt_created":"2015-12-03 21:15:14","changed":"1475894618","gmt_changed":"2016-10-08 02:43:38","alt":"IGERT Trainees with NSF Director","file":{"fid":"192953","name":"nsf_pres_igert_trainees.jpg","image_path":"\/sites\/default\/files\/images\/nsf_pres_igert_trainees_1.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/nsf_pres_igert_trainees_1.jpg","mime":"image\/jpeg","size":2760045,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/nsf_pres_igert_trainees_1.jpg?itok=IFpZue-j"}}},"media_ids":["70375"],"related_links":[{"url":"http:\/\/www.ibb.gatech.edu\/","title":"Petit Institute for Bioengineering and Bioscience"},{"url":"http:\/\/www.gatech.edu\/calendar\/event.html?nid=70046","title":"2011 IBB Distinguished Lecture - NSF director"},{"url":"http:\/\/www.stemcelligert.gatech.edu\/","title":"Stem Cell Biomanufacturing IGERT"}],"groups":[{"id":"65446","name":"IBB Training Grant - Stem Cell Biomanufacturing IGERT"}],"categories":[],"keywords":[{"id":"10506","name":"IGERT"},{"id":"363","name":"NSF"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003EMegan Richards\u003C\/p\u003E","format":"limited_html"}],"email":["megan.richards@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"70130":{"#nid":"70130","#data":{"type":"news","title":"Transformative NIH Grant Will Support Development of Tissue Regeneration Therapeutics","body":[{"value":"\u003Cp\u003EThe National Institutes of Health (NIH) has awarded nearly $2 million to researchers at the Georgia Institute of Technology and Emory University to develop a new class of therapeutics for treating traumatic injuries and degenerative diseases.\u003C\/p\u003E\u003Cp\u003EThe five-year project focuses on developing biomaterials capable of capturing certain molecules from embryonic stem cells and delivering them to wound sites to enhance tissue regeneration in adults. By applying these unique molecules, clinicians may be able to harness the regenerative power of stem cells while avoiding concerns of tumor formation and immune system compatibility associated with most stem cell transplantation approaches.\u003C\/p\u003E\u003Cp\u003E\u0022Pre-clinical and clinical evidence strongly suggests that the biomolecules produced by stem cells significantly impact tissue regeneration independent of differentiation into functionally competent cells,\u0022 said Todd McDevitt, director of the Stem Cell Engineering Center at Georgia Tech and an associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. \u0022We want to find out if the signaling molecules responsible for scarless wound healing and functional tissue restoration during early stages of embryological development can be used with adult wounds to produce successful tissue regeneration without scar formation.\u0022\u003C\/p\u003E\u003Cp\u003EIn addition to McDevitt, Coulter Department associate professor Johnna Temenoff and Woodruff School of Mechanical Engineering professor Robert Guldberg are also investigators on the project.\u003C\/p\u003E\u003Cp\u003ERegenerative medicine seeks to restore normal structure and function to tissues compromised by degenerative diseases and traumatic injuries. The contrast between embryonic and adult wound healing suggests that molecules that facilitate tissue regeneration during embryonic development are distinctly different from those of adult tissues.\u003C\/p\u003E\u003Cp\u003EThis grant includes plans for engineering biomaterials that can efficiently capture morphogens, which are molecules secreted by embryonic stem cells undergoing differentiation. The study will also evaluate the regenerative activity of molecule-filled biomaterials in animal models of dermal wound healing, hind limb ischemia and bone fractures. Examining the effects of the morphogens on a range of animal wound models will increase the likelihood of success and define any limitations of the technology, such as its use for specific tissues or injuries.\u003C\/p\u003E\u003Cp\u003E\u0022Biomaterials have largely been used in an attempt to direct stem cell differentiation or serve as passive cell transplantation vehicles for regenerative medicine and tissue engineering purposes,\u0022 said McDevitt, who is also a Petit Faculty Fellow in the Institute for Bioengineering and Bioscience at Georgia Tech. \u0022The idea of specifically engineering biomaterial properties to capture and deliver complex assemblies of stem cell-derived morphogens without transplanting the cells themselves represents a novel strategy to translate the potency of stem cells into a viable regenerative medicine therapy.\u0022\u003C\/p\u003E\u003Cp\u003EThe award was one of 17 granted this year through the NIH Director\u0027s Transformative Research Projects Program (T-R01), which was created to challenge the status quo with innovative ideas that have the potential to advance fields and speed the translation of research into improved health for the American public.\u003C\/p\u003E\u003Cp\u003EAnother T-R01 grant was awarded to Coulter Department professor Shuming Nie, associate professor May Wang and University of Pennsylvania School of Medicine Thoracic Surgery Research Laboratory director Sunil Singhal. That $7 million, five-year grant will support continuing work by the Emory-Georgia Tech Nanotechnology Center for Personalized and Predictive Oncology team on developing fluorescent nanoparticle probes that hone in on cancer cells and on creating instruments that visualize them for cancer detection during surgery.\u003C\/p\u003E\u003Cp\u003ESince its inception in 2009, the NIH Director\u0027s Award Program has funded a total of 406 high-risk research projects, including 79 T-R01 awards.\u003C\/p\u003E\u003Cp\u003E\u0022The NIH Director\u0027s Award programs reinvigorate the biomedical work force by providing unique opportunities to conduct research that is neither incremental nor conventional,\u0022 said James M. Anderson, director of the Division of Program Coordination, Planning and Strategic Initiatives, who guides the NIH Common Fund\u0027s High-Risk Research program. \u0022The awards are intended to catalyze giant leaps forward for any area of biomedical research, allowing investigators to go in entirely new directions.\u0022\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EResearch News \u0026amp; Publications Office\u003Cbr \/\u003E Georgia Institute of Technology\u003Cbr \/\u003E 75 Fifth Street, N.W., Suite 314\u003Cbr \/\u003E Atlanta, Georgia 30308 USA\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EMedia Relations Contacts:\u003C\/strong\u003E Abby Robinson (abby@innovate.gatech.edu; 404-385-3364) or John Toon (jtoon@gatech.edu; 404-894-6986)\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EWriter:\u003C\/strong\u003E Abby Robinson\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EThe National Institutes of Health (NIH) has awarded nearly $2 million to researchers at the Georgia Institute of Technology and Emory University to develop a new class of therapeutics for treating traumatic injuries and degenerative diseases.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Transformative NIH grant awarded to Georgia Tech and Emory researchers."}],"uid":"27206","created_gmt":"2011-09-20 00:00:00","changed_gmt":"2016-10-08 03:10:09","author":"Abby Vogel Robinson","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2011-09-20T00:00:00-04:00","iso_date":"2011-09-20T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"70131":{"id":"70131","type":"image","title":"Todd McDevitt","body":null,"created":"1449177288","gmt_created":"2015-12-03 21:14:48","changed":"1475894616","gmt_changed":"2016-10-08 02:43:36"},"70132":{"id":"70132","type":"image","title":"Todd McDevitt\/Marissa Cooke\/Alyssa Ngangan","body":null,"created":"1449177288","gmt_created":"2015-12-03 21:14:48","changed":"1475894616","gmt_changed":"2016-10-08 02:43:36"},"70133":{"id":"70133","type":"image","title":"Todd McDevitt\/Marissa Cooke\/Alyssa Ngangan","body":null,"created":"1449177288","gmt_created":"2015-12-03 21:14:48","changed":"1475894616","gmt_changed":"2016-10-08 02:43:36"}},"media_ids":["70131","70132","70133"],"related_links":[{"url":"http:\/\/www.bme.gatech.edu\/facultystaff\/faculty_record.php?id=78","title":"Todd McDevitt"},{"url":"http:\/\/www.bme.gatech.edu\/facultystaff\/faculty_record.php?id=84","title":"Johnna Temenoff"},{"url":"http:\/\/www.me.gatech.edu\/faculty\/guldberg.shtml","title":"Robert Guldberg"},{"url":"http:\/\/www.bme.gatech.edu\/","title":"Wallace H. Coulter Department of Biomedical Engineering"},{"url":"http:\/\/www.me.gatech.edu\/","title":"George W. Woodruff School of Mechanical Engineering"}],"groups":[{"id":"1188","name":"Research Horizons"}],"categories":[{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"135","name":"Research"}],"keywords":[{"id":"3024","name":"biomaterials"},{"id":"594","name":"college of engineering"},{"id":"14376","name":"Degenerative Diseases"},{"id":"11533","name":"Department of Biomedical Engineering"},{"id":"14370","name":"Johnna Temenoff"},{"id":"14371","name":"morphogen"},{"id":"2076","name":"NIH"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Cstrong\u003EAbby Robinson\u003C\/strong\u003E\u003Cbr \/\u003EResearch News and Publications\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=avogel6\u0022\u003EContact Abby Robinson\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-385-3364\u003C\/strong\u003E\u003C\/p\u003E","format":"limited_html"}],"email":["abby@innovate.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"68527":{"#nid":"68527","#data":{"type":"news","title":"Obama Taps Georgia Tech President for National Manufacturing Steering Committee","body":[{"value":"\u003Cp\u003EPresident Barack Obama today named Georgia Tech President G. P. \u201cBud\u201d Peterson to the Advanced Manufacturing Partnership steering committee. The partnership will bring together industry, universities and the federal government to identify and invest in the key emerging technologies, such as information technology, biotechnology and nanotechnology. The national initiative is designed to help U.S. manufacturers improve cost, quality and speed of production in order to remain globally competitive.\u003C\/p\u003E\u003Cp\u003E\u201cWe applaud this initiative, and Georgia Tech is honored to collaborate to identify ways to strengthen the manufacturing sector to help create jobs in Georgia and across the United States,\u201d said Peterson, who also serves as a member of the Secretary of Commerce\u0027s National Advisory Council on Innovation and Entrepreneurship.\u003C\/p\u003E\u003Cp\u003EThe steering committee will guide the efforts of industry leaders, federal agency heads and university presidents, and will partner universities with industry and government agencies to develop new research and education agendas related to advanced manufacturing.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003EThe president also announced a new National Robotics Initiative as part of the advanced manufacturing and technology focus. Henrik Christensen, KUKA Chair of Robotics for Georgia Tech, serves as an academic and research leader on the National Robotics Initiative.\u003C\/p\u003E\u003Cp\u003EAccording to Christensen, this is a critical time for the U.S. While the last 25 years saw tremendous progress due to the Internet, the next game-changing revolution will be robotics.\u003C\/p\u003E\u003Cp\u003E\u201cRobotics technology addresses a number of our nation\u2019s most critical needs, including reinvigorating the U.S. manufacturing base, protecting our citizens and soldiers, caring for our aging population, preserving our environment, and reducing our dependence on foreign oil,\u201d Christensen said. \u201cThrough the National Robotics Initiative, the United States can regain our leadership position from Europe, Japan and South Korea, both in terms of basic research and in terms of the application of the technology to secure future growth. As home to one of the nation\u2019s top robotics programs, Georgia Tech is an enthusiastic member of this strategic effort.\u201d\u003C\/p\u003E\u003Cp\u003EThe Advanced Manufacturing Partnership will commit to form a multiuniversity, collaborative framework for the sharing of educational materials and best practices relating to advanced manufacturing and its linkage to the innovation.\u003C\/p\u003E\u003Cp\u003ESusan Hockfield, president of the Massachusetts Institute of Technology and Andrew Liveries of Dow Chemical are chairing the Advanced Manufacturing Partnership steering committee.\u0026nbsp; In addition to Peterson, other committee members include University of California at Berkley Chancellor Robert Birgeneau, University of Michigan President Mary Sue Coleman, Stanford President John Hennessy and Carnegie Mellon President Jared Cohon.\u003C\/p\u003E\u003Cp\u003E\u201cMany of our challenges can be solved through innovation and fostering an entrepreneurial environment, as well as collaboration between industry, education and government to create a healthy economic environment and an educated workforce,\u201d Peterson said. \u201cThis collaborative effort will facilitate job creation and global competitiveness and is a component of Georgia Tech\u2019s strategic plan.\u201d\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"College of Computing Professor Leads National Robotics Roadmap"}],"field_summary":[{"value":"\u003Cp\u003E President Barack Obama today named Georgia Tech President G. P. \u201cBud\u201d Peterson to the Advanced Manufacturing Partnership steering committee. \u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"President Barack Obama today named Georgia Tech President Peterson to the Advanced Manufacturing Partnership steering committee."}],"uid":"27304","created_gmt":"2011-06-24 11:40:08","changed_gmt":"2016-10-08 03:09:37","author":"Matthew Nagel","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2011-06-24T00:00:00-04:00","iso_date":"2011-06-24T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"66420":{"id":"66420","type":"image","title":"G.P. \u0022Bud\u0022 Peterson","body":null,"created":"1449177169","gmt_created":"2015-12-03 21:12:49","changed":"1475894589","gmt_changed":"2016-10-08 02:43:09","alt":"G.P. \u0022Bud\u0022 Peterson","file":{"fid":"193311","name":"g.p._bud_peterson.jpg","image_path":"\/sites\/default\/files\/images\/g.p._bud_peterson_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/g.p._bud_peterson_0.jpg","mime":"image\/jpeg","size":2186478,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/g.p._bud_peterson_0.jpg?itok=-Z2U6fP5"}},"66193":{"id":"66193","type":"image","title":"Henrik Christen with robot","body":null,"created":"1449176931","gmt_created":"2015-12-03 21:08:51","changed":"1475894587","gmt_changed":"2016-10-08 02:43:07"}},"media_ids":["66420","66193"],"related_links":[{"url":"http:\/\/www.gatech.edu\/president\/","title":"Georgia Tech President G.P. (Bud) Peterson"},{"url":"http:\/\/www.whitehouse.gov\/the-press-office\/2011\/06\/24\/president-obama-launches-advanced-manufacturing-partnership","title":"White House press release"},{"url":"http:\/\/www.whitehouse.gov\/the-press-office\/2011\/06\/24\/background-president-s-event-pittsburgh-pennsylvania-today","title":"Background on Event"}],"groups":[{"id":"1183","name":"Home"}],"categories":[{"id":"129","name":"Institute and Campus"}],"keywords":[{"id":"13503","name":"Advanced Manufactuing"},{"id":"13504","name":"Advanced Manufacturing Partnership steering committee"},{"id":"654","name":"College of Computing"},{"id":"2675","name":"economic"},{"id":"11890","name":"henrik christensen"},{"id":"215","name":"manufacturing"},{"id":"13502","name":"President G.P."},{"id":"769","name":"President Obama"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Cstrong\u003EGeorgia Tech Media Relations\u003C\/strong\u003E\u003Cbr \/\u003ELaura Diamond\u003Cbr \/\u003E\u003Ca href=\u0022mailto:laura.diamond@comm.gatech.edu\u0022\u003Elaura.diamond@comm.gatech.edu\u003C\/a\u003E\u003Cbr \/\u003E404-894-6016\u003Cbr \/\u003EJason Maderer\u003Cbr \/\u003E\u003Ca href=\u0022mailto:maderer@gatech.edu\u0022\u003Emaderer@gatech.edu\u003C\/a\u003E\u003Cbr \/\u003E404-660-2926\u003C\/p\u003E","format":"limited_html"}],"email":["mattnagel@gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"66531":{"#nid":"66531","#data":{"type":"news","title":"Nature Magazine features GT\u0027s \u0022Out-of-the-box\u0022 Stem Cell Biomanufacturing IGERT","body":[{"value":"\u003Cp\u003EThe Stem Cell Biomanufacturing IGERT program at the Georgia Institute of Technology was mentioned in Nature Magazine on June 9\u003Csup\u003Eth\u003C\/sup\u003E in \u003Ca href=\u0022http:\/\/www.nature.com\/naturejobs\/science\/articles\/10.1038\/nj7350-241a\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003EGrowing with the flow\u003C\/em\u003E\u003C\/a\u003E by Meredith Wadman as one of the few programs providing young researchers with \u201coutside-the-box opportunities\u201d for stem cell research amidst the funding feud.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003ELast year, the appeal to repeal the injunction blocking the NIH from funding research using embryonic stem cells was passed. A second victory for scientists recently occurred when courts ruled that \u201cthe Department of Health and Human Services would not prevent future presidents or Congresses from acting anew to limit government funding for research.\u201d However, there is still some public opposition to using human embryos for research. The NIH will fund $125 million to stem cell research this year alone, but scientists are wary knowing this funding comes without long-term security.\u003C\/p\u003E\u003Cp\u003EThe article details programs available to young scientist considering careers in stem-cell research in the US and around the world. Ms. Wadman recommended stem cell PhD programs at Stanford, the Sackler Institute of Graduate Biomedical Sciences at New York University School of Medicine, the University of Minnesota, and the Hanover Biomedical Research School in Germany.\u003C\/p\u003E\u003Cp\u003EShe also commented on \u201cthe emerging need for biomanufacturures with stem-cell experitise, as exemplified by a new PhD prgoramme in stem-cell biomanufacturing at the Georgia Institute of Technology, funded by the US National Science Foundation. The programme opened its doors last year and is admitting six students per year. \u201cIf stem cells are going to move out of the lab, there will be lots of need for engineers to produce a large number of identical cells,\u201d says Aaron Levine, assistant professor of public policy at Georgia Tech and researcher involved in the IGERT.\u003C\/p\u003E\u003Cp\u003EThe Stem Cell Biomanufacturing IGERT program is headed by co-directors, Todd McDevitt, PhD and Bob Nerem, PhD, and offers enormous promise for researchers to become experts in stem cell biomanufacturing for the development of cell-based therapies, including regenerative medicine, drug discovery and development, cell-based diagnostics, and cancer. With funding for the next 4 years, this IGERT program is transforming the potential of stem cells for PhD scientists and engineers.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.nature.com\/naturejobs\/science\/articles\/10.1038\/nj7350-241a\u0022 target=\u0022_blank\u0022\u003EView Article Here.\u003C\/a\u003E\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Stem Cell Biomanufacturing IGERT featured in Nature Magazine"}],"field_summary":[{"value":"\u003Cp\u003EThe Stem Cell Biomanufacturing IGERT program at the Georgia Institute of Technology was mentioned in Nature Magazine on June 9\u003Csup\u003Eth\u003C\/sup\u003E \u0026nbsp;in \u003Cem\u003EGrowing with the flow\u003C\/em\u003E by Meredith Wadman as one of the few programs providing young researchers with \u201coutside-the-box opportunities\u201d for stem cell research amidst the funding feud.\u0026nbsp;\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"The IGERT program is providing young researchers with \u201coutside-the-box opportunities\u201d for stem cell research amidst the funding feud"}],"uid":"27487","created_gmt":"2011-06-15 11:20:41","changed_gmt":"2016-10-08 03:08:53","author":"Megan Richards","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2011-06-15T00:00:00-04:00","iso_date":"2011-06-15T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"66532":{"id":"66532","type":"image","title":"Stem Cells","body":null,"created":"1449177176","gmt_created":"2015-12-03 21:12:56","changed":"1475894592","gmt_changed":"2016-10-08 02:43:12","alt":"Stem Cells","file":{"fid":"193318","name":"e3500x.jpg","image_path":"\/sites\/default\/files\/images\/e3500x_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/e3500x_0.jpg","mime":"image\/jpeg","size":289298,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/e3500x_0.jpg?itok=V2RyB95-"}}},"media_ids":["66532"],"related_links":[{"url":"http:\/\/www.nature.com\/naturejobs\/2011\/110609\/full\/nj7350-241a.html","title":"Biomedical Research: Growing with the flow"},{"url":"http:\/\/www.stemcelligert.gatech.edu\/about","title":"Stem Cell IGERT website"},{"url":"http:\/\/ibb.gatech.edu\/","title":"Parker H. Petit Institute for Bioengineering and Bioscience"},{"url":"http:\/\/center.ibb.gatech.edu\/scec\/hg_news\/66531","title":"SCEC"}],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"134","name":"Student and Faculty"}],"keywords":[{"id":"9555","name":"aaron levine"},{"id":"10506","name":"IGERT"},{"id":"3803","name":"nature"},{"id":"167499","name":"Stem Cell Biomanufacturing"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003EMegan Richards\u003C\/p\u003E","format":"limited_html"}],"email":["megan.richards@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"66035":{"#nid":"66035","#data":{"type":"news","title":"Georgia Tech Hosts Workshop on Stem Cell Engineering","body":[{"value":"\u003Cp\u003EGeorgia Tech\u2019s Stem Cell Engineering Center is hosting a half-day workshop on May 9, 2011 at the Institute for Bioengineering and Bioscience. \u0026nbsp;Seventy-five scientists and trainees from seven different departments at Georgia Tech, Emory University, Morehouse School of Medicine and the University of Georgia are convening to discuss research from various fields relating to stem cell engineering. \u0026nbsp;\u003C\/p\u003E\u003Cp\u003EAligned with the mission of the Stem Cell Engineering Center, the purpose of this workshop is to cultivate teams of researchers from the basic sciences to address key hurdles and technological challenges currently impeding the development of stem cell therapeutics and diagnostics. \u0026nbsp;\u003C\/p\u003E\u003Cp\u003EStem cells, or unspecialized cells, hold tremendous promise as a biological resource for regenerative medicine therapies, pharmaceutical discovery and development, and cell-based diagnostic assays. Transforming the potential of stem cells into viable biomedical technologies and commercial applications is dependent on developing efficient, robust, non-destructive and scalable strategies to control, assay and manufacture stem cells and stem cell-derived products. \u0026nbsp;\u003C\/p\u003E\u003Cp\u003EMany of the unique challenges posed by stem cell research could be addressed by applying innovative technological advances occurring in adjacent disciplines for similar purposes, but different applications. Presentations during the workshop will include talks on differentiation technologies, bioanalytical techniques, multi-scale phenotypic analysis and stem cell biomanufacturing. \u0026nbsp;\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EGeorgia Tech hosts half-day workshop on stem cell engineering\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"The goal of workshop is to build inter-institutional partnerships and collaborations"}],"uid":"27195","created_gmt":"2011-05-09 13:13:30","changed_gmt":"2016-10-08 03:08:41","author":"Colly Mitchell","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2011-05-09T00:00:00-04:00","iso_date":"2011-05-09T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"66036":{"id":"66036","type":"image","title":"Stem cell bioprocessing","body":null,"created":"1449176916","gmt_created":"2015-12-03 21:08:36","changed":"1475894585","gmt_changed":"2016-10-08 02:43:05","alt":"Stem cell bioprocessing","file":{"fid":"192455","name":"stem_cell_image.jpg","image_path":"\/sites\/default\/files\/images\/stem_cell_image_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/stem_cell_image_0.jpg","mime":"image\/jpeg","size":9078,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/stem_cell_image_0.jpg?itok=qac1y6g7"}}},"media_ids":["66036"],"related_links":[{"url":"http:\/\/www.ibb.gatech.edu\/","title":"Petit Institute for Bioengineering and Bioscience"},{"url":"http:\/\/scec.gatech.edu\/","title":"Stem Cell Engineering Center"}],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"140","name":"Cancer Research"},{"id":"132","name":"Institute Leadership"},{"id":"134","name":"Student and Faculty"},{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"150","name":"Physics and Physical Sciences"}],"keywords":[{"id":"13085","name":"Georgia Tech hosting workshop on stem cell engineering"},{"id":"248","name":"IBB"},{"id":"760","name":"Todd McDevitt"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003EColly Mitchell\u003C\/p\u003E","format":"limited_html"}],"email":["colly.mitchell@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"66544":{"#nid":"66544","#data":{"type":"news","title":"Engineers Control the Environment to Direct Stem Cell Differentiation","body":[{"value":"\u003Cp\u003EStem cell technologies have been proposed for cell-based diagnostics and regenerative medicine therapies. However, being able to make stem cells efficiently develop into a desired cell type -- such as muscle, skin, blood vessels, bone or neurons -- limits the clinical potential of these technologies.\u003C\/p\u003E\u003Cp\u003ENew research presented on June 16, 2011 at the annual meeting of the International Society for Stem Cell Research (ISSCR) shows that systematically controlling the local and global environments during stem cell development helps to effectively direct the process of differentiation. In the future, these findings could be used to develop manufacturing procedures for producing large quantities of stem cells for diagnostic and therapeutic applications. The research is sponsored by the National Science Foundation and the National Institutes of Health.\u003C\/p\u003E\u003Cp\u003E\u0022Stem cells don\u0027t make any decisions in isolation; their decisions are spatially and temporally directed by biochemical and mechanical cues in their environment,\u0022 said Todd McDevitt, director of the Stem Cell Engineering Center at Georgia Tech and an associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. \u0022We have designed systems that allow us to tightly control these properties during stem cell differentiation, but also give us the flexibility to introduce a new growth factor or shake the cells a little faster to see how changes like these affect the outcome.\u0022\u003C\/p\u003E\u003Cp\u003EThese systems can also be used to compare the suitability of specific stem cell types for a particular use.\u003C\/p\u003E\u003Cp\u003E\u0022We have developed several platforms that will allow us to conduct head-to-head studies with different kinds of stem cells to determine if one type of stem cell outperforms another type for a certain application,\u0022 said McDevitt, who is also a Petit Faculty Fellow in the Institute for Bioengineering and Bioscience at Georgia Tech.\u003C\/p\u003E\u003Cp\u003EMany laboratory growth methods allow stem cells to aggregate in three-dimensional clumps called \u0022embryoid bodies\u0022 during differentiation. McDevitt and biomedical engineering graduate student Andres Bratt-Leal incorporated biomaterial particles directly within these aggregates during their formation. They introduced microparticles made of gelatin, poly(lactic-co-glycolic acid) (PLGA) or agarose and tested their impact on the assembly, intercellular communication and morphogenesis of the stem cell aggregates under different conditions by varying the microsphere-to-cell ratio and the size of the microspheres.\u003C\/p\u003E\u003Cp\u003EThe researchers found that the presence of the biomaterials alone modulated embryoid body differentiation, but did not adversely affect cell viability. Compared to typical delivery methods, providing differentiation factors -- retinoic acid, bone morphogenetic protein 4 (BMP4) and vascular endothelial growth factor (VEGF) -- via microparticles induced changes in the gene and protein expression patterns of the aggregates.\u003C\/p\u003E\u003Cp\u003EBy including tiny magnetic particles into the embryoid bodies during formation, the researchers also found they could use a magnet to spatially control the location of an aggregate and its assembly with other aggregates. The magnetic particles remained entrapped within the aggregates for the duration of the experiments but did not adversely affect cell viability or differentiation.\u003C\/p\u003E\u003Cp\u003E\u0022With biomaterial and magnetic microparticles, we are beginning to be able to recreate the types of complex geometric patterns seen during early development, which require multiple cues at the same time and the ability to spatially and temporally control their local presentation,\u0022 noted McDevitt.\u003C\/p\u003E\u003Cp\u003EWhile microparticles can be used to control differentiation by regulating the local environment, other methods exist to control differentiation through the global environment. Experiments by McDevitt and biomedical engineering graduate student Melissa Kinney have demonstrated that modulating hydrodynamic conditions can dictate the morphology of cell aggregate formation and control the expression of differentiated phenotypic cell markers.\u003C\/p\u003E\u003Cp\u003E\u0022Because bioreactors typically impose hydrodynamic forces on cells to cultivate large volumes of cells at high density, our use of hydrodynamics to control cell fate decisions represents a novel, yet simple, principle that could be used in the future for the scalable efficient production of stem cells,\u0022 added McDevitt.\u003C\/p\u003E\u003Cp\u003ETechnologies capable of being directly integrated into bioprocessing systems will be the best choice for manufacturing large batches of stem cells, he noted. In the future, the development of multi-scale techniques that combine different levels of control -- both local and global -- to regulate stem cell differentiation may help the translation of stem cells into viable clinical therapies.\u003C\/p\u003E\u003Cp\u003E\u003Cem\u003EThis project is supported by the National Science Foundation (NSF) (Award No. CBET 0651739) and the National Institutes of Health (NIH) (R01GM088291). The content is solely the responsibility of the principal investigator and does not necessarily represent the official views of the NSF or NIH.\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EResearch News \u0026amp; Publications Office\u003Cbr \/\u003E Georgia Institute of Technology\u003Cbr \/\u003E 75 Fifth Street, N.W., Suite 314\u003Cbr \/\u003E Atlanta, Georgia 30308 USA\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EMedia Relations Contacts: \u003C\/strong\u003EAbby Robinson (abby@innovate.gatech.edu; 404-385-3364) or John Toon (jtoon@gatech.edu; 404-894-6986)\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EWriter: \u003C\/strong\u003EAbby Robinson\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003ENew research shows that systematically controlling the local and global environments during stem cell development helps to effectively direct their differentiation.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Controlling the environment during stem cell development matters."}],"uid":"27206","created_gmt":"2011-06-16 00:00:00","changed_gmt":"2016-10-08 03:08:53","author":"Abby Vogel Robinson","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2011-06-16T00:00:00-04:00","iso_date":"2011-06-16T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"66545":{"id":"66545","type":"image","title":"Todd McDevitt","body":null,"created":"1449177176","gmt_created":"2015-12-03 21:12:56","changed":"1475894592","gmt_changed":"2016-10-08 02:43:12"},"66546":{"id":"66546","type":"image","title":"Magnetic embryoid bodies","body":null,"created":"1449177176","gmt_created":"2015-12-03 21:12:56","changed":"1475894592","gmt_changed":"2016-10-08 02:43:12"},"66547":{"id":"66547","type":"image","title":"Shaking stem cells","body":null,"created":"1449177176","gmt_created":"2015-12-03 21:12:56","changed":"1475894592","gmt_changed":"2016-10-08 02:43:12"}},"media_ids":["66545","66546","66547"],"related_links":[{"url":"http:\/\/www.bme.gatech.edu\/facultystaff\/faculty_record.php?id=78","title":"Todd McDevitt"},{"url":"http:\/\/www.bme.gatech.edu\/","title":"Wallace H. Coulter Department of Biomedical Engineering"},{"url":"http:\/\/scec.gatech.edu\/","title":"Stem Cell Engineering Center"},{"url":"http:\/\/www.ibb.gatech.edu\/","title":"Petit Institute for Bioengineering and Bioscience"}],"groups":[{"id":"1188","name":"Research Horizons"}],"categories":[{"id":"141","name":"Chemistry and Chemical Engineering"},{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"135","name":"Research"}],"keywords":[{"id":"594","name":"college of engineering"},{"id":"11533","name":"Department of Biomedical Engineering"},{"id":"13436","name":"embryoid bodies"},{"id":"7663","name":"magnetic particles"},{"id":"167413","name":"Stem Cell"},{"id":"171090","name":"Stem Cell Biology"},{"id":"171010","name":"Stem Cell Development"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Cstrong\u003EAbby Robinson\u003C\/strong\u003E\u003Cbr \/\u003EResearch News and Publications\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=avogel6\u0022\u003EContact Abby Robinson\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-385-3364\u003C\/strong\u003E\u003C\/p\u003E","format":"limited_html"}],"email":["abby@innovate.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"66434":{"#nid":"66434","#data":{"type":"news","title":"Todd McDevitt Discusses the Development of Stem Cell Therapies on CNN","body":[{"value":"\u003Cp\u003EOn May 16th, Todd McDevitt, PhD, co-PI of the\nstem cell biomanufacturing IGERT program at Georgia Tech and director of the\nStem Cell Engineering Center was broadcasted live on CNN to discuss the\ndevelopment of stem cell based therapies and treatment options.\u0026nbsp; \u003C\/p\u003E\n\n\u003Cp\u003EThe discussion detailed how stem cell therapies are advancing\nfrom research labs to clinical applications at a cautious but accelerated pace.\nThe reason: stem cells serve as the body\u2019s most promising treatment option as\nthey have the potential to develop into many different types of cells including: blood cells, nerve\ncells and muscle cells. However, there are many facets to stem cells therapies\nthat are still unclear. \u003C\/p\u003E\u003Cp\u003EDr. McDevitt explained the importance of researching all\naspects of stem cells to better understand the effects of the stem cell\ntherapies being developed and more importantly which stem cells are best for\nthe job. Currently, the Department of Defense is using stem cell therapies to\ntreat wounded soldiers and more research is\nbeing done to repair spinal cords and damage caused by traumatic brain\ninjuries. He stressed that the unknowns of stem cell therapies are still being discovered\nand further study is necessary to find the best stem cell treatment for each\nspecific problem. \u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Stem Cell Therapies on CNN"}],"field_summary":[{"value":"\u003Cp\u003ETodd McDevitt, PhD,\nco-PI of the stem cell biomanufacturing IGERT program at Georgia Tech and\ndirector of the Stem Cell Engineering Center was broadcasted live on CNN to\ndiscuss the development of stem cell based therapies and treatment\noptions. \u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Stem cells serve as the body\u2019s most promising treatment option because of their  potential to develop into many different types of cells"}],"uid":"27487","created_gmt":"2011-06-08 15:49:14","changed_gmt":"2016-10-08 03:08:49","author":"Megan Richards","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2011-06-08T00:00:00-04:00","iso_date":"2011-06-08T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"66435":{"id":"66435","type":"image","title":"Stem Cell","body":null,"created":"1449177169","gmt_created":"2015-12-03 21:12:49","changed":"1475894589","gmt_changed":"2016-10-08 02:43:09","alt":"Stem Cell","file":{"fid":"192533","name":"o1500x.jpg","image_path":"\/sites\/default\/files\/images\/o1500x_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/o1500x_0.jpg","mime":"image\/jpeg","size":118445,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/o1500x_0.jpg?itok=DpVYOFJN"}}},"media_ids":["66435"],"related_links":[{"url":"http:\/\/scec.gatech.edu\/","title":"Stem Cell Engineering Center"},{"url":"http:\/\/mcdevittlab.bme.gatech.edu\/","title":"McDevitt Lab"},{"url":"http:\/\/bme.gatech.edu\/","title":"Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University"},{"url":"http:\/\/www.cnn.com\/video\/data\/2.0\/video\/world\/2011\/05\/17\/analyzing.stem.cell.research.cnn.html","title":"View CNN interview"}],"groups":[{"id":"65425","name":"IBB Center - SCEC"}],"categories":[],"keywords":[{"id":"760","name":"Todd McDevitt"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Cem\u003EMegan Richards\u003C\/em\u003E\u003Cbr \/\u003EResearch Program Coordinator\u003Cbr \/\u003EInstitute of Bioengineering \u0026amp; Bioscience\u003Cbr \/\u003EGeorgia Institute of Technology\u003Cbr \/\u003E\u003Ca href=\u0022mailto:megan.richards@ibb.gatech.edu\u0022 target=\u0022_blank\u0022\u003Emegan.richards@ibb.gatech.edu\u003C\/a\u003E\u003C\/p\u003E","format":"limited_html"}],"email":["megan.richards@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"63646":{"#nid":"63646","#data":{"type":"news","title":"Georgia Tech Faculty Members Influencing Georgia","body":[{"value":"\u003Cp\u003EEach year, Georgia Trend Magazine announces their \u0022100 Most Influential Georgian\u0027s list\u0022 and\u0026nbsp; the 2011 list included Bud Peterson, Georgia Tech\u0027s President, for the second year. \u003Cbr \/\u003E\u003Cbr \/\u003EIn addition to our President, three faculty members from the Institute for Bioengineering and Bioscience (IBB) were named to the \u0022100 Most Influential \u2013 \u0027Notables\u0027\u0022 list, also for the second year in a row.\u0026nbsp; Todd McDevitt, associate professor in Biomedical Engineering and the director of the Stem Cell Engineering Center, Bob Nerem, professor in Mechanical Engineering and director of the Georgia Tech and Emory Center for Regenerative Medicine and Steve Stice, director of the Regenerative Bioscience Center at the University of Georgia, Georgia Research Alliance Scholar and Chief Scientific Officer of Aruna Biomedical.\u003Cbr \/\u003E\u003Cbr \/\u003EGeorgia Trend Magazine does not take nominations for the most influential awards, rather they chose these people based on the events and news from the year and create these lists based on the notion that these are the people that \u0022will affect the course of events in Georgia\u0022 in the future. \u0026nbsp;\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EIn addition to our President, three IBB faculty members were named to\nthe \u0022100 Most Influential \u2013 \u0027Notables\u0027\u0022 list, also for the second year\nin a row.\u0026nbsp; Todd McDevitt, Associate Professor in Biomedical Engineering\nand the Director of the Stem Cell Engineering Center, Bob Nerem,\nProfessor in Mechanical Engineering and Director of the Georgia Tech\nand Emory Center for Regenerative Medicine and Steve Stice, Director of\nthe Regenerative Bioscience Center at the University of Georgia,\nGeorgia Research Alliance Scholar and Chief Scientific Officer of Aruna\nBiomedical.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Georgia Tech Faculty Members Influencing Georgia"}],"uid":"27224","created_gmt":"2011-01-17 11:43:27","changed_gmt":"2016-10-08 03:08:02","author":"Megan McDevitt","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2011-01-17T00:00:00-05:00","iso_date":"2011-01-17T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"63970":{"id":"63970","type":"image","title":"Robert Nerem, Steven Stice, Todd McDevitt","body":null,"created":"1449176708","gmt_created":"2015-12-03 21:05:08","changed":"1475894512","gmt_changed":"2016-10-08 02:41:52","alt":"Robert Nerem, Steven Stice, Todd McDevitt","file":{"fid":"191908","name":"_TAB0059_0.jpg","image_path":"\/sites\/default\/files\/images\/_TAB0059_0_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/_TAB0059_0_0.jpg","mime":"image\/jpeg","size":1930764,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/_TAB0059_0_0.jpg?itok=0laoHV2B"}}},"media_ids":["63970"],"related_links":[{"url":"http:\/\/www.georgiatrend.com\/cover-story\/01_11_notables.shtml","title":"Georgia Trend Notables List"},{"url":"http:\/\/ibb.gatech.edu\/","title":"Parker H. Petit Institute for Bioengineering and Bioscience"},{"url":"http:\/\/gtec.gatech.edu\/","title":"GTEC Website"},{"url":"http:\/\/scec.gatech.edu\/","title":"Stem Cell Engineering Center"}],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"141","name":"Chemistry and Chemical Engineering"},{"id":"134","name":"Student and Faculty"},{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"149","name":"Nanotechnology and Nanoscience"},{"id":"135","name":"Research"}],"keywords":[{"id":"11644","name":"Georgia Trend"},{"id":"1487","name":"GTEC"},{"id":"3414","name":"Robert Nerem"},{"id":"167604","name":"stem cell engineering center"},{"id":"169293","name":"Steven Stice"},{"id":"760","name":"Todd McDevitt"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003EColly Mitchell\u003Cbr \/\u003ESpecial Projects Coordinator, Makreting \u0026amp; Events\u003C\/p\u003E","format":"limited_html"}],"email":["colly.mitchell@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"63942":{"#nid":"63942","#data":{"type":"news","title":"Georgia Tech and TERMIS Partner for 2013 Annual Meeting","body":[{"value":"\u003Cp\u003EThe Tissue Engineering and Regenerative Medicine International Society (TERMIS) will partner with the Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech in 2013 by hosting its annual North American Conference in Atlanta. \u003Cbr \/\u003E \u003Cbr \/\u003ETwo members of the Petit Institute\u2019s faculty have been designated to head the 2013 TERMIS conference. The conference chair will be Robert E. Guldberg, Ph.D., the director of the Petit Institute and professor in mechanical engineering and the program chair will be Todd McDevitt, PhD, associate professor in biomedical engineering and the director of the Stem Cell Engineering Center at Georgia Tech. \u003Cbr \/\u003E \u003Cbr \/\u003E\u201cWe are honored to be selected and look forward to putting on a great meeting,\u201d Guldberg said. TERMIS brings together an international community to promote discussion of the scientific challenges and therapeutic benefits for the development and application of the tissue engineering and regenerative medicine fields. TERMIS\u2019 mission is to promote worldwide science and technology advancement and education in these fields. It does so through regular worldwide conferences, publishing the Tissue Engineering journal that it endorses and providing quarterly newsletters and other communications for its members. \u003Cbr \/\u003E \u003Cbr \/\u003E\u201cBob and I are dedicated to creating a dynamic program that will honor the meetings of the past as well as introduce some new elements,\u201d McDevitt remarked. TERMIS has been evolving over the last decade. Its roots began in 2001 as an annual workshop called \u201cTissue Growth Engineering\u201d that was organized by the Pittsburgh Tissue Engineering Initiative. In 2004, this small workshop evolved into the larger, national meeting called Regenerate. In 2006, the Regenerate World Congress was held in Pittsburgh where the meeting had grown significantly and had a large international following. By the following year, the society was rebranded into TERMIS to encompass its international presence. The society has continued to grow and now has chapters in Europe and Asia. TERMIS is open to anyone engaged in research in the tissue engineering or regenerative medicine arenas. \u003Cbr \/\u003E \u003Cbr \/\u003EThe 2011 TERMIS North American conference was held in Houston, Texas and in 2012 the entire society will come together for the TERMIS World Congress in Vienna, Austria.\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EThe Tissue Engineering and Regenerative Medicine International Society (TERMIS) will partner with the Institute for Bioengineering and Bioscience (IBB) at Georgia Tech in 2013 by hosting its annual North American Conference in Atlanta.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Georgia Tech and TERMIS Partner for 2013 Annual Meeting"}],"uid":"27224","created_gmt":"2011-01-14 01:00:00","changed_gmt":"2016-10-08 03:08:06","author":"Megan McDevitt","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2011-01-18T00:00:00-05:00","iso_date":"2011-01-18T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"64111":{"id":"64111","type":"image","title":"TERMIS","body":null,"created":"1449176720","gmt_created":"2015-12-03 21:05:20","changed":"1475894559","gmt_changed":"2016-10-08 02:42:39","alt":"TERMIS","file":{"fid":"191940","name":"termis_logo_1.jpg","image_path":"\/sites\/default\/files\/images\/termis_logo_1_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/termis_logo_1_0.jpg","mime":"image\/jpeg","size":127070,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/termis_logo_1_0.jpg?itok=ha69ZdMV"}}},"media_ids":["64111"],"related_links":[{"url":"http:\/\/ibb.gatech.edu\/","title":"Parker H. Petit Institute for Bioengineering and Bioscience"},{"url":"http:\/\/www.termis.org\/","title":"TERMIS"},{"url":"http:\/\/scec.gatech.edu\/","title":"Stem Cell Engineering Center"}],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"129","name":"Institute and Campus"},{"id":"131","name":"Economic Development and Policy"},{"id":"132","name":"Institute Leadership"},{"id":"141","name":"Chemistry and Chemical Engineering"},{"id":"133","name":"Special Events and Guest Speakers"},{"id":"134","name":"Student and Faculty"},{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"149","name":"Nanotechnology and Nanoscience"},{"id":"135","name":"Research"}],"keywords":[{"id":"1489","name":"Regenerative Medicine"},{"id":"11629","name":"Robert Guldberg"},{"id":"4891","name":"Tissue Engineering"},{"id":"760","name":"Todd McDevitt"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Cstrong\u003EMegan McDevitt\u003C\/strong\u003E\u003Cbr \/\u003EIBB\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=mm504\u0022\u003EContact Megan McDevitt\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-385-7001\u003C\/strong\u003E\u003C\/p\u003E","format":"limited_html"}],"email":["megan.mcdevitt@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"48923":{"#nid":"48923","#data":{"type":"news","title":"Delivering Stem Cells Improves Repair of Major Bone Injuries in Rats","body":[{"value":"\u003Cp\u003EA study published this week reinforces the potential value of stem cells in repairing major injuries involving the loss of bone structure.  \u003C\/p\u003E\n\u003Cp\u003EThe study shows that delivering stem cells on a polymer scaffold to treat large areas of missing bone leads to improved bone formation and better mechanical properties compared to treatment with the scaffold alone. This type of therapeutic treatment could be a potential alternative to bone grafting operations.\n\u003C\/p\u003E\n\u003Cp\u003E\u0022Massive bone injuries are among the most challenging problems that orthopedic surgeons face, and they are commonly seen as a result of accidents as well as in soldiers returning from war,\u0022 said the study\u0027s lead author Robert Guldberg, a professor in Georgia Tech\u0027s Woodruff School of Mechanical Engineering. \u0022This study shows that there is promise in treating these injuries by delivering stem cells to the injury site. These are injuries that would not heal without significant medical intervention.\u0022\n\u003C\/p\u003E\n\u003Cp\u003EDetails of the research were published in the early edition of the journal \u003Cem\u003EProceedings of the National Academy of Sciences\u003C\/em\u003E on January 11, 2010. This work was funded by the National Institutes of Health and the National Science Foundation.\n\u003C\/p\u003E\n\u003Cp\u003EThe study was conducted in rats in which two bone gaps eight millimeters in length were created to simulate massive injuries. One gap was treated with a polymer scaffold seeded with stem cells and the other with scaffold only. The results showed that injuries treated with the stem cell scaffolds showed significantly more bone growth than injuries treated with scaffolds only. \n\u003C\/p\u003E\n\u003Cp\u003EGuldberg and mechanical engineering graduate student Kenneth Dupont experimented with scaffolds containing two different types of human stem cells -- bone marrow-derived mesenchymal adult stem cells and amniotic fluid fetal stem cells. \n\u003C\/p\u003E\n\u003Cp\u003E\u0022We were able to directly evaluate the therapeutic potential of human stem cells to repair large bone defects by implanting them into rats with a reduced immune system,\u0022 explained Guldberg, who is also the director of the Petit Institute for Bioengineering and Bioscience at Georgia Tech.\u003C\/p\u003E\n\u003Cp\u003EMicro-CT measurements showed no significant differences in bone regeneration between the two stem cell groups. However, combining the two types of stem cells produced significantly higher bone volume and strength compared to scaffolds without cellular augmentation.\n\u003C\/p\u003E\n\u003Cp\u003EAlthough stem cell delivery significantly enhanced bone growth and biomechanical properties, it was not able to consistently repair the injury. Eight weeks after the treatment, new bone bridged the gaps in four of nine defects treated with scaffolds seeded with adult stem cells, one of nine defects treated with scaffolds seeded with fetal stem cells, and none of the defects treated with the scaffold alone.\n\u003C\/p\u003E\n\u003Cp\u003E\u0022We thought that the functional regeneration of the bone defects may have been limited by stem cells migrating away from the injury site, so we decided to investigate the fate and distribution of the delivered cells,\u0022 said Guldberg.\n\u003C\/p\u003E\n\u003Cp\u003ETo do this, Guldberg labeled stem cells with fluorescent quantum dots -- nanometer-scale particles that emit light when excited by near-infrared radiation -- to track the distribution of stem cells after delivery on the scaffolds and completed the same experiments as previously described. \n\u003C\/p\u003E\n\u003Cp\u003EThroughout the entire study, the researchers observed significant fluorescence at the stem cell scaffold sites. However, beginning seven to 10 days after treatment, signals appeared at the scaffold-only sites. Additional analysis with immunostaining revealed that the quantum dots present at the scaffold-only sites were contained in inflammatory cells called macrophages that had taken up quantum dots released from dead stem cells.\n\u003C\/p\u003E\n\u003Cp\u003E\u0022While our overall study shows that stem cell therapy has a lot of promise for treating massive bone defects, this experiment shows that we still need to develop an improved way of delivering the stem cells so that they stay alive longer and thus remain at the injury site longer,\u0022 explained Guldberg.\u003C\/p\u003E\n\u003Cp\u003EThe researchers also found that the quantum dots diminished the function of the transplanted stem cells and thus their therapeutic effect. When the stem cells were labeled with quantum dots, the results showed a failure to enhance bone formation or bridge defects. However, the same low concentration of quantum dots did not affect cell viability or the ability of the stem cells to become bone cells in laboratory studies. \n\u003C\/p\u003E\n\u003Cp\u003E\u0022Although in vitro laboratory studies remain important, this work provides further evidence that well-characterized in vivo models are necessary to test the ability of regenerative tissue strategies to effectively integrate and restore function in complex living organisms,\u0022 added Guldberg. \u0022Improved methods of non-invasive cell tracking that do not alter cell function in vivo are needed to optimize stem cell delivery strategies and compare the effectiveness of different stem cell sources for tissue regeneration.\u0022\n\u003C\/p\u003E\n\u003Cp\u003EGuldberg is currently exploring alternative cell tracking methods, such as genetically modifying the stem cells to express green fluorescent protein and\/or other luminescent enzymes such as luciferase. He is also investigating the addition of programming cues to the scaffold that will direct the stem cells to differentiate into bone cells. These signals may be particularly effective for fetal stem cells, which are believed to be more primitive than adult stem cells, according to Guldberg. \n\u003C\/p\u003E\n\u003Cp\u003ELessons learned from the current work are also being applied to develop effective stem cell therapies for severe composite injuries to multiple tissues including bone, nerve, vasculature and muscle. This follow-on work is being conducted in the Georgia Tech Center for Advanced Bioengineering for Soldier Survivability in collaboration with Ravi Bellamkonda and Barbara Boyan, professors in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.\n\u003C\/p\u003E\n\u003Cp\u003EOther authors on the paper include Andres Garcia, professor and Woodruff Faculty Fellow in Georgia Tech\u0027s Woodruff School of Mechanical Engineering and the Petit Institute for Bioengineering and Bioscience; Georgia Tech research scientist Hazel Stevens, Georgia Tech graduate student Joel Boerckel; and National University of Ireland medical student Kapil Sharma.\n\u003C\/p\u003E\n\u003Cp\u003E\u003Cem\u003EThis work was funded by grant number R01-AR051336 from the National Institutes of Health (NIH) and by grant number EEC-9731643 from the National Science Foundation (NSF). The content is solely the responsibility of the principal investigator and does not necessarily represent the official views of the NIH or NSF.\u003C\/em\u003E\n\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EResearch News \u0026amp; Publications Office\u003Cbr \/\u003E\nGeorgia Institute of Technology\u003Cbr \/\u003E\n75 Fifth Street, N.W., Suite 314\u003Cbr \/\u003E\nAtlanta, Georgia  30308  USA\n\u003C\/strong\u003E\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EMedia Relations Contacts:\u003C\/strong\u003E Abby Vogel (avogel@gatech.edu; 404-385-3364) or John Toon (jtoon@gatech.edu; 404-894-6986).\n\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EWriter:\u003C\/strong\u003E Abby Vogel\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"A new study published this week shows that delivering stem cells on a polymer scaffold to treat large areas of missing bone leads to improved bone formation and better mechanical properties compared to treatment with scaffold alone.","format":"limited_html"}],"field_summary_sentence":[{"value":"Study reinforces potential value of stem cells to repair bone in"}],"uid":"27206","created_gmt":"2010-01-11 01:00:00","changed_gmt":"2016-10-08 03:04:04","author":"Abby Vogel Robinson","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2010-01-11T00:00:00-05:00","iso_date":"2010-01-11T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"48924":{"id":"48924","type":"image","title":"Robert Guldberg bone regeneration","body":null,"created":"1449175408","gmt_created":"2015-12-03 20:43:28","changed":"1475894463","gmt_changed":"2016-10-08 02:41:03","alt":"Robert Guldberg bone regeneration","file":{"fid":"101291","name":"try39853.jpg","image_path":"\/sites\/default\/files\/images\/try39853_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/try39853_0.jpg","mime":"image\/jpeg","size":1255705,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/try39853_0.jpg?itok=V0huypJw"}},"48925":{"id":"48925","type":"image","title":"Bone regeneration with stem cell scaffold","body":null,"created":"1449175408","gmt_created":"2015-12-03 20:43:28","changed":"1475894463","gmt_changed":"2016-10-08 02:41:03","alt":"Bone regeneration with stem cell scaffold","file":{"fid":"101292","name":"tyd39853.jpg","image_path":"\/sites\/default\/files\/images\/tyd39853_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tyd39853_0.jpg","mime":"image\/jpeg","size":405535,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tyd39853_0.jpg?itok=SU7f1o5P"}},"48926":{"id":"48926","type":"image","title":"Robert Guldberg bone regeneration","body":null,"created":"1449175408","gmt_created":"2015-12-03 20:43:28","changed":"1475894463","gmt_changed":"2016-10-08 02:41:03","alt":"Robert Guldberg bone regeneration","file":{"fid":"101293","name":"the39853.jpg","image_path":"\/sites\/default\/files\/images\/the39853_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/the39853_0.jpg","mime":"image\/jpeg","size":1050118,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/the39853_0.jpg?itok=crlQN6aN"}}},"media_ids":["48924","48925","48926"],"related_links":[{"url":"http:\/\/www.me.gatech.edu\/faculty\/guldberg.shtml","title":"Robert Guldberg"},{"url":"http:\/\/www.me.gatech.edu\/","title":"George W. Woodruff School of Mechanical Engineering"},{"url":"http:\/\/www.ibb.gatech.edu\/","title":"Petit Institute for Bioengineering and Bioscience"}],"groups":[{"id":"1188","name":"Research Horizons"}],"categories":[{"id":"145","name":"Engineering"},{"id":"135","name":"Research"}],"keywords":[{"id":"8233","name":"amniotic fluid fetal stem cells"},{"id":"530","name":"bone"},{"id":"8227","name":"bone defect"},{"id":"8231","name":"Bone Marrow Derived Stem Cells"},{"id":"8226","name":"Bone Regeneration"},{"id":"8225","name":"Bone Repair"},{"id":"8232","name":"fetal stem cells"},{"id":"6891","name":"fluorescence"},{"id":"8230","name":"Mesenchymal Stem Cells"},{"id":"8228","name":"Orthopedics"},{"id":"8229","name":"polymer scaffold"},{"id":"2363","name":"quantum dots"},{"id":"1489","name":"Regenerative Medicine"},{"id":"167413","name":"Stem Cell"},{"id":"167139","name":"Stem Cell Research"},{"id":"167130","name":"Stem Cells"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Cstrong\u003EAbby Vogel\u003C\/strong\u003E\u003Cbr \/\u003EResearch News and Publications\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=avogel6\u0022\u003EContact Abby Vogel\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-385-3364\u003C\/strong\u003E\u003C\/p\u003E","format":"limited_html"}],"email":["avogel@gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"63104":{"#nid":"63104","#data":{"type":"news","title":"States Now Fund Majority of Human Embryonic Stem Cell Research","body":[{"value":"\u003Cp\u003EStates, not the federal government, now fund the majority of\nhuman embryonic stem cell research conducted in the United States, according to\na recent study in the journal Nature Biotechnology.\u0026nbsp; In addition, states varied substantially in\nthe extent to which they prioritized human embryonic stem cell research, and\nmuch of the research performed in the states could likely have been funded by\nthe National Institutes of Health under federal guidelines established by\nPresident Bush in 2001. \u003C\/p\u003E\n\n\n\n\u003Cp\u003E\u201cWhile the federal government still contributes more to stem\ncell research overall, each year since 2007 these six states have funded more\nhuman embryonic stem cell research than the federal government,\u201d said Aaron\nLevine, assistant professor at Georgia Tech. \u003C\/p\u003E\n\n\n\n\u003Cp\u003ELevine created an online searchable database (\u003Ca href=\u0022http:\/\/www.stemcellstates.net\/\u0022\u003Ehttp:\/\/www.stemcellstates.net\/\u003C\/a\u003E) that\nallows users to find detailed information about each grant given out by the six\nstates that adopted programs specifically to fund stem cell research. The\ndatabase currently covers grants given out by California, Connecticut,\nIllinois, Maryland, New Jersey and New York from December 2005 to December 2009,\nand will be updated yearly with new information.\u003C\/p\u003E\n\n\n\n\u003Cp\u003E\u201cFrom what I could tell, only a relatively small portion of\nthe stem cell research supported by these states was clearly ineligible for\nfederal funding,\u201d said Levine, who is on the faculty of the School of Public\nPolicy in the Ivan Allen College of Liberal Arts.\u003C\/p\u003E\n\n\n\n\u003Cp\u003ELevine reasons this could be a result of the fact that there\nare many incentives for scientists to work with existing human embryonic stem\ncell lines rather than creating new ones. \u003C\/p\u003E\n\n\n\n\u003Cp\u003EHe said he was surprised at how great the difference was\namong states in the share of grants that supported human embryonic stem cell\nresearch. While Connecticut and California devoted 97 percent and 75 percent of\ntheir grants to this research, New Jersey and New York steered only 21 percent\nto this contentious field. \u003C\/p\u003E\n\n\n\n\u003Cp\u003EOne reason for these differences may be the development of\ninduced pluripotent stem cells, which are derived from adult body cells rather\nthan from embryos.\u0026nbsp; More recent programs,\nsuch as New York\u2019s, may be disproportionally focusing on this new technology.\u003C\/p\u003E\n\n\n\n\n\n\u003Cp\u003E\u201cThere\u2019s no question that these\nstate programs drew a lot of scientists into the field,\u201d said Levine.\u0026nbsp; \u201cAn interesting question going forward is how\ncommitted these scientists are to stem cell research or if they are relating\ntheir work to stem cells now simply to be eligible for state funding \u2013 that\u2019s\nunknown right now.\u201d\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EStates, not the federal government, now fund the majority of\nhuman embryonic stem cell research conducted in the United States, according to\na study by Aaron Levine in the journal Nature Biotechnology.\u0026nbsp; In addition, much of the research performed\nin the states could likely have been funded by the National Institutes of\nHealth under federal guidelines established by President Bush in 2001.\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Aaron Levine created an online searchable database showing funding information from the six states that adopted stem cell research programs."}],"uid":"27310","created_gmt":"2010-12-09 09:34:26","changed_gmt":"2016-10-08 03:07:54","author":"David Terraso","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2010-12-09T00:00:00-05:00","iso_date":"2010-12-09T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"58921":{"id":"58921","type":"image","title":"Dr. Aaron Levine","body":null,"created":"1449176204","gmt_created":"2015-12-03 20:56:44","changed":"1475894517","gmt_changed":"2016-10-08 02:41:57","alt":"Dr. Aaron Levine","file":{"fid":"190783","name":"tpb15085.jpg","image_path":"\/sites\/default\/files\/images\/tpb15085_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tpb15085_0.jpg","mime":"image\/jpeg","size":35289,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tpb15085_0.jpg?itok=pzt1U1lx"}},"63103":{"id":"63103","type":"image","title":"State Stem Cell Programs v. Federal Programs","body":null,"created":"1449176649","gmt_created":"2015-12-03 21:04:09","changed":"1475894552","gmt_changed":"2016-10-08 02:42:32","alt":"State Stem Cell Programs v. Federal Programs","file":{"fid":"191732","name":"Levine_NBT_Figure1.gif","image_path":"\/sites\/default\/files\/images\/Levine_NBT_Figure1_0.gif","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/Levine_NBT_Figure1_0.gif","mime":"image\/gif","size":28815,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/Levine_NBT_Figure1_0.gif?itok=25PA4Gqq"}},"63102":{"id":"63102","type":"image","title":"State Stem Cell Programs","body":null,"created":"1449176649","gmt_created":"2015-12-03 21:04:09","changed":"1475894552","gmt_changed":"2016-10-08 02:42:32","alt":"State Stem Cell Programs","file":{"fid":"191731","name":"Screen_shot_2010-12-08_at_12.18.33_PM.png","image_path":"\/sites\/default\/files\/images\/Screen_shot_2010-12-08_at_12.18.33_PM_0.png","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/Screen_shot_2010-12-08_at_12.18.33_PM_0.png","mime":"image\/png","size":134239,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/Screen_shot_2010-12-08_at_12.18.33_PM_0.png?itok=sdHKTPZZ"}}},"media_ids":["58921","63103","63102"],"groups":[{"id":"1183","name":"Home"}],"categories":[{"id":"146","name":"Life Sciences and Biology"}],"keywords":[{"id":"949","name":"ivan allen"},{"id":"8996","name":"levine"},{"id":"626","name":"public policy"},{"id":"167413","name":"Stem Cell"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Cstrong\u003EGeorgia Tech Media Relations\u003C\/strong\u003E\u003Cbr \/\u003ELaura Diamond\u003Cbr \/\u003E\u003Ca href=\u0022mailto:laura.diamond@comm.gatech.edu\u0022\u003Elaura.diamond@comm.gatech.edu\u003C\/a\u003E\u003Cbr \/\u003E404-894-6016\u003Cbr \/\u003EJason Maderer\u003Cbr \/\u003E\u003Ca href=\u0022mailto:maderer@gatech.edu\u0022\u003Emaderer@gatech.edu\u003C\/a\u003E\u003Cbr \/\u003E404-660-2926\u003C\/p\u003E","format":"limited_html"}],"email":["david.terraso@comm.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"60431":{"#nid":"60431","#data":{"type":"news","title":"NSF Awards $3M Stem Cell Bio-Manufacturing Program to Georgia Tech","body":[{"value":"\u003Cp\u003EThe National Science Foundation (NSF) has awarded $3 million to the Georgia Institute of Technology to fund a unique research program on stem cell bio-manufacturing. The program is specifically focused on developing engineering methods for stem cell production, in order to meet the anticipated demand for stem cells. The award comes through the NSF\u0027s Integrative Graduate Education and Research Traineeship (IGERT) Program, which supports innovation in graduate education in fields that cross academic disciplines and have broad societal impact.\u003C\/p\u003E\u003Cp\u003EWhile stem cell research is on the verge of broadly impacting many elements of the medical field -- regenerative medicine, drug discovery and development, cell-based diagnostics and cancer -- the bio-process engineering that will be required to manufacture sufficient quantities of functional stem cells for these diagnostic and therapeutic purposes has not been rigorously explored. \u003C\/p\u003E\u003Cp\u003E\u0022Successfully integrating knowledge of stem cell biology with bioprocess engineering and process development into single individuals is the challenging goal of this program,\u0022 said Todd McDevitt, an associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University and a Petit Faculty Fellow in the Parker H. Petit Institute for Bioengineering and Biosciences at Georgia Tech. \u003C\/p\u003E\u003Cp\u003EMcDevitt is leading the IGERT with Robert M. Nerem, professor emeritus of the George W. Woodruff School of Mechanical Engineering at Georgia Tech. Nerem is also director of the Georgia Tech\/Emory Center (GTEC) for Regenerative Medicine, which will administer this award.\u003C\/p\u003E\u003Cp\u003EPh.D. students funded by Georgia Tech\u0027s stem cell bio-manufacturing IGERT will receive interdisciplinary educational training in the biology, engineering, enabling technologies, commercialization and public policy related to stem cells. Their research efforts will focus on developing innovative engineering approaches to bridge the gap between basic discoveries made in stem cell biology and therapeutic stem cell-based technologies. \u003C\/p\u003E\u003Cp\u003E\u0022This program provides a unique opportunity for engineers to generate standardized and quantitative methods for stem cell isolation, characterization, propagation and differentiation,\u0022 said Nerem. \u0022These techniques must be developed in a scalable manner to efficiently produce sufficient numbers of stem cells and derivatives in accessible formats in order to yield a spectrum of novel therapeutic and diagnostic applications of stem cells.\u0022 \u003C\/p\u003E\u003Cp\u003EThe Georgia Tech program is centered around three main research thrusts, which focus on several critical technologies that must be developed to enable the application and use of stem cell-based products: \u003C\/p\u003E\u003Cp\u003E\u2022 Creating reproducible, controlled and scalable methods to expand and differentiate stem cells with defined phenotypes and epigenetic states. \u003C\/p\u003E\u003Cp\u003E\u2022 Developing reliable, rapid and quantifiable methods to characterize the composition and function of stem cells to be generated. \u003C\/p\u003E\u003Cp\u003E\u2022 Designing low-cost systems capable of producing large populations of defined stem cells and derivatives.\u003C\/p\u003E\u003Cp\u003EStudents in the program will be able to take advantage of the core facilities provided by the new Stem Cell Engineering Center at Georgia Tech, which is directed by McDevitt. Technologies developed by the students supported through this IGERT will be rapidly integrated into academic and industrial stem cell practices and cell-based products. \u003C\/p\u003E\u003Cp\u003EThe award will support 30 new Ph.D. students over the next five years and brings together more than two dozen faculty members from Georgia Tech, Emory University, the University of Georgia and the Morehouse School of Medicine. In addition, plans are being made for students to participate in international research collaborations with the National University of Ireland at Galway, Imperial College London, the University of Cambridge and the University of Toronto. \u003C\/p\u003E\u003Cp\u003E\u0022We anticipate this program will produce the future leaders and innovators in the field of stem cell bio-manufacturing who will contribute significantly at the interface of stem cell engineering, biology and therapy,\u0022 added McDevitt. \u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EResearch News \u0026amp; Publications Office\u003Cbr \/\u003EGeorgia Institute of Technology\u003Cbr \/\u003E75 Fifth Street, N.W., Suite 314\u003Cbr \/\u003EAtlanta, Georgia 30308 USA \u003C\/strong\u003E Abby Vogel Robinson (404-385-3364; \u003Ca href=\u0022mailto:abby@innovate.gatech.edu\u0022\u003Eabby@innovate.gatech.edu\u003C\/a\u003E) or John Toon (404-894-6986; \u003Ca href=\u0022mailto:jtoon@gatech.edu\u0022\u003Ejtoon@gatech.edu\u003C\/a\u003E) \u003C\/p\u003E\u003Cp\u003EMedia Relations Contacts:\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EWriter:\u003C\/strong\u003E Abby Vogel Robinson\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Nerem and McDevitt will lead Integrative Graduate Education and Research Traineeship (IGERT) Program"}],"field_summary":[{"value":"\u003Cp\u003EThe NSF has awarded $3 million to Georgia Tech to fund a unique research program on stem cell bio-manufacturing. The effort is focused on developing engineering methods for stem cell production to meet the anticipated demand for stem cells.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"A stem cell bio-manufacturing research and education program award has been awarded to Georgia Tech."}],"uid":"27206","created_gmt":"2010-08-15 00:00:00","changed_gmt":"2016-10-08 03:07:15","author":"Abby Vogel Robinson","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2010-08-16T00:00:00-04:00","iso_date":"2010-08-16T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"60432":{"id":"60432","type":"image","title":"Todd McDevitt","body":null,"created":"1449176267","gmt_created":"2015-12-03 20:57:47","changed":"1475894523","gmt_changed":"2016-10-08 02:42:03","alt":"Todd McDevitt","file":{"fid":"191123","name":"tnh17927.jpg","image_path":"\/sites\/default\/files\/images\/tnh17927_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tnh17927_0.jpg","mime":"image\/jpeg","size":1233833,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tnh17927_0.jpg?itok=vgTJzXrP"}},"60433":{"id":"60433","type":"image","title":"Robert Nerem","body":null,"created":"1449176267","gmt_created":"2015-12-03 20:57:47","changed":"1475894523","gmt_changed":"2016-10-08 02:42:03","alt":"Robert Nerem","file":{"fid":"191124","name":"tao17927.jpg","image_path":"\/sites\/default\/files\/images\/tao17927_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tao17927_0.jpg","mime":"image\/jpeg","size":1376960,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tao17927_0.jpg?itok=cUXTKsm5"}},"60434":{"id":"60434","type":"image","title":"Robert Nerem \u0026 Todd McDevitt","body":null,"created":"1449176267","gmt_created":"2015-12-03 20:57:47","changed":"1475894523","gmt_changed":"2016-10-08 02:42:03","alt":"Robert Nerem \u0026 Todd McDevitt","file":{"fid":"191125","name":"tpb17928.jpg","image_path":"\/sites\/default\/files\/images\/tpb17928_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tpb17928_0.jpg","mime":"image\/jpeg","size":1599704,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tpb17928_0.jpg?itok=qHDHZJYj"}}},"media_ids":["60432","60433","60434"],"related_links":[{"url":"http:\/\/www.me.gatech.edu\/faculty\/nerem.shtml","title":"Robert Nerem"},{"url":"http:\/\/www.bme.gatech.edu\/facultystaff\/faculty_record.php?id=78","title":"Todd McDevitt"},{"url":"http:\/\/www.me.gatech.edu\/","title":"George W. Woodruff School of Mechanical Engineering"},{"url":"http:\/\/www.bme.gatech.edu\/","title":"Wallace H. Coulter Department of Biomedical Engineering"}],"groups":[{"id":"1188","name":"Research Horizons"}],"categories":[{"id":"140","name":"Cancer Research"},{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"135","name":"Research"}],"keywords":[{"id":"167413","name":"Stem Cell"},{"id":"171009","name":"stem cell bio-manufacturing"},{"id":"171010","name":"Stem Cell Development"},{"id":"169496","name":"stem cell differentiation"},{"id":"171011","name":"stem cell industry"},{"id":"171012","name":"stem cell production"},{"id":"167139","name":"Stem Cell Research"},{"id":"171013","name":"stem cell therapy"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Cstrong\u003EAbby Vogel Robinson\u003C\/strong\u003E\u003Cbr \/\u003EResearch News and Publications\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=avogel6\u0022\u003EContact Abby Vogel Robinson\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-385-3364\u003C\/strong\u003E\u003C\/p\u003E","format":"limited_html"}],"email":["abby@innovate.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"56455":{"#nid":"56455","#data":{"type":"news","title":"Delivery of Adult Versus Fetal Stem Cells for Bone Regeneration","body":[{"value":"\u003Cp\u003E\u003Cstrong\u003EEngineered Delivery of Adult Versus Fetal Stem Cells for Bone Regeneration\u003C\/strong\u003E\n\u003C\/p\u003E\n\u003Cp\u003EAlexandra Peister and her collaborators received an NIH program project grant which will support research at Morehouse, Georgia Institute of Technology, University of Rochester, Emory University, and the University of Queensland in Australia. The grant will be funded for the next two years and will support research at Morehouse at a level of $36,000 per year. Co-Investigator, NIH Challenge Grant (American Recovery and Reinvestment Act funded): Engineered Delivery of Adult Versus Fetal Stem Cells for Bone Regeneration in collaboration with Georgia Tech. The grant will be funded September 2009.\n\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"Alexandra Peister and her collaborators received an NIH program project grant which will support research at Morehouse, Georgia Institute of Technology, University of Rochester, Emory University, and the University of Queensland in Australia.","format":"limited_html"}],"field_summary_sentence":[{"value":"Delivery of Adult Versus Fetal Stem Cells for Bone Regeneration"}],"uid":"27349","created_gmt":"2009-10-14 00:00:00","changed_gmt":"2016-10-08 03:06:11","author":"Floyd Wood","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2009-10-14T00:00:00-04:00","iso_date":"2009-10-14T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"56456":{"id":"56456","type":"image","title":"Dr. Alexandra Peister","body":null,"created":"1449175653","gmt_created":"2015-12-03 20:47:33","changed":"1475894501","gmt_changed":"2016-10-08 02:41:41","alt":"Dr. Alexandra Peister","file":{"fid":"190475","name":"tor48197.jpg","image_path":"\/sites\/default\/files\/images\/tor48197_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tor48197_0.jpg","mime":"image\/jpeg","size":31305,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tor48197_0.jpg?itok=o-sEj3UK"}}},"media_ids":["56456"],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"129","name":"Institute and Campus"},{"id":"141","name":"Chemistry and Chemical Engineering"},{"id":"134","name":"Student and Faculty"},{"id":"145","name":"Engineering"},{"id":"135","name":"Research"}],"keywords":[{"id":"8226","name":"Bone Regeneration"},{"id":"247","name":"Emory"},{"id":"109","name":"Georgia Tech"},{"id":"9556","name":"Morehouse College"},{"id":"167413","name":"Stem Cell"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cstrong\u003EFloyd Wood\u003C\/strong\u003E\u003Cbr \/\u003EIBB\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=fwood3\u0022\u003EContact Floyd Wood\u003C\/a\u003E","format":"limited_html"}],"email":["floyd.wood@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"56433":{"#nid":"56433","#data":{"type":"news","title":"Stem Cells Could Be Big Business for Georgia","body":[{"value":"\u003Cp\u003EColumn by Steve L. Stice, Director of the UGA Regenerative Bioscience Center and Robert M. Nerem, Parker H. Petit Distinguished Chair for Engineering in Medicine, Institute Professor,and Director of the Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech.\n\u003C\/p\u003E\n\u003Cp\u003EPresident-elect Obama\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"Column by Steve L. Stice of the UGA Regenerative Bioscience Center and Robert M. Nerem, Parker H. Petit Distinguished Chair for Engineering in Medicine, Institute Professor,and Director of the Parker H. Petit Institute for Bioengineering and Bioscience.","format":"limited_html"}],"field_summary_sentence":[{"value":"Stem Cells Could Be Big Business for Georgia"}],"uid":"27195","created_gmt":"2009-01-21 01:00:00","changed_gmt":"2016-10-08 03:06:06","author":"Colly Mitchell","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2009-01-18T00:00:00-05:00","iso_date":"2009-01-18T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"129","name":"Institute and Campus"},{"id":"155","name":"Congressional Testimony"},{"id":"140","name":"Cancer Research"},{"id":"141","name":"Chemistry and Chemical Engineering"},{"id":"134","name":"Student and Faculty"},{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"135","name":"Research"}],"keywords":[{"id":"109","name":"Georgia Tech"},{"id":"1516","name":"Nerem"},{"id":"167413","name":"Stem Cell"},{"id":"170975","name":"Stice"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cstrong\u003EColly Mitchell\u003C\/strong\u003E\u003Cbr \/\u003EParker H. Petit Institute for Bioengineering and Bioscience\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=cmitchell6\u0022\u003EContact Colly Mitchell\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-894-5982\u003C\/strong\u003E","format":"limited_html"}],"email":["colly.mitchell@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}}}